<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38257821</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Myocardial Oedema as a Consequence of Viral Infection and Persistence-A Narrative Review with Focus on COVID-19 and Post COVID Sequelae.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16010121</ELocationID><Abstract><AbstractText>Microvascular integrity is a critical factor in myocardial fluid homeostasis. The subtle equilibrium between capillary filtration and lymphatic fluid removal is disturbed during pathological processes leading to inflammation, but also in hypoxia or due to alterations in vascular perfusion and coagulability. The degradation of the glycocalyx as the main component of the endothelial filtration barrier as well as pericyte disintegration results in the accumulation of interstitial and intracellular water. Moreover, lymphatic dysfunction evokes an increase in metabolic waste products, cytokines and inflammatory cells in the interstitial space contributing to myocardial oedema formation. This leads to myocardial stiffness and impaired contractility, eventually resulting in cardiomyocyte apoptosis, myocardial remodelling and fibrosis. The following article reviews pathophysiological inflammatory processes leading to myocardial oedema including myocarditis, ischaemia-reperfusion injury and viral infections with a special focus on the pathomechanisms evoked by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In addition, clinical implications including potential long-term effects due to viral persistence (long COVID), as well as treatment options, are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Panagiotides</LastName><ForeName>Noel G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0002-5246-8241</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poledniczek</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6091-9823</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreas</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;lsmann</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocher</LastName><ForeName>Alfred A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopp</LastName><ForeName>Christoph W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piechota-Polanczyk</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8062-4435</Identifier><AffiliationInfo><Affiliation>Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, 90-752 &#x141;&#xf3;d&#x17a;, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weidenhammer</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavo</LastName><ForeName>Noemi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadowski</LastName><ForeName>Patricia P</ForeName><Initials>PP</Initials><Identifier Source="ORCID">0000-0003-2462-4515</Identifier><AffiliationInfo><Affiliation>Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004487" MajorTopicYN="N">Edema</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">glycocalyx</Keyword><Keyword MajorTopicYN="N">microcirculation</Keyword><Keyword MajorTopicYN="N">myocardial oedema</Keyword><Keyword MajorTopicYN="N">platelets</Keyword></KeywordList><CoiStatement>All authors declare no conflict of interest directly related to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38257821</ArticleId><ArticleId IdType="pmc">PMC10818479</ArticleId><ArticleId IdType="doi">10.3390/v16010121</ArticleId><ArticleId IdType="pii">v16010121</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vasques-N&#xf3;voa F., Ang&#xe9;lico-Gon&#xe7;alves A., Alvarenga J.M.G., Nobrega J., Cerqueira R.J., Mancio J., Leite-Moreira A.F., Roncon-Albuquerque R. Myocardial oedema: Pathophysiological basis and implications for the failing heart. ESC Heart Fail. 2022;9:958&#x2013;976. doi: 10.1002/ehf2.13775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13775</ArticleId><ArticleId IdType="pmc">PMC8934951</ArticleId><ArticleId IdType="pubmed">35150087</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehlhorn U., Geissler H.J., Laine G.A., Allen S.J. Myocardial fluid balance. Eur. J. Cardio-Thorac. Surg. 2001;20:1220&#x2013;1230. doi: 10.1016/S1010-7940(01)01031-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(01)01031-4</ArticleId><ArticleId IdType="pubmed">11717032</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine G.A., Allen S.J. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ. Res. 1991;68:1713&#x2013;1721. doi: 10.1161/01.RES.68.6.1713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.68.6.1713</ArticleId><ArticleId IdType="pubmed">2036720</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai K.V., Laine G.A., Stewart R.H., Cox C.S., Quick C.M., Allen S.J., Fischer U.M. Mechanics of the left ventricular myocardial interstitium: Effects of acute and chronic myocardial edema. Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2428&#x2013;H2434. doi: 10.1152/ajpheart.00860.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00860.2007</ArticleId><ArticleId IdType="pubmed">18375722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubboli A., Sobotka P.A., Euler D.E. Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am. J. Physiol.-Heart Circ. Physiol. 1994;267:H1054&#x2013;H1061. doi: 10.1152/ajpheart.1994.267.3.H1054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1994.267.3.H1054</ArticleId><ArticleId IdType="pubmed">8092270</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto M., McClure D.E., Schertel E.R., Andrews P.J., Jones G.A., Pratt J.W., Ross P., Myerowitz P.D. Effects of hypoproteinemia-induced myocardial edema on left ventricular function. Am. J. Physiol. 1998;274:H937&#x2013;H944. doi: 10.1152/ajpheart.1998.274.3.H937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1998.274.3.H937</ArticleId><ArticleId IdType="pubmed">9530207</ArticleId></ArticleIdList></Reference><Reference><Citation>Karolle B.L., Carlson R.E., Aisen A.M., Buda A.J. Transmural distribution of myocardial edema by NMR relaxometry following myocardial ischemia and reperfusion. Am. Heart J. 1991;122:655&#x2013;664. doi: 10.1016/0002-8703(91)90508-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(91)90508-F</ArticleId><ArticleId IdType="pubmed">1877442</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ttgen R., Christiani R., Freyhardt P., Gutberlet M., Schultheiss H.P., Hamm B., K&#xfc;hl U. Magnetic resonance imaging findings in acute myocarditis and correlation with immunohistological parameters. Eur. Radiol. 2011;21:1259&#x2013;1266. doi: 10.1007/s00330-010-2022-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-010-2022-1</ArticleId><ArticleId IdType="pmc">PMC3088804</ArticleId><ArticleId IdType="pubmed">21116631</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich M.G., Strohm O., Schulz-Menger J., Marciniak H., Luft F.C., Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 1998;97:1802&#x2013;1809. doi: 10.1161/01.CIR.97.18.1802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.97.18.1802</ArticleId><ArticleId IdType="pubmed">9603535</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Dorado D., Andres-Villarreal M., Ruiz-Meana M., Inserte J., Barba I. Myocardial edema: A translational view. J. Mol. Cell. Cardiol. 2012;52:931&#x2013;939. doi: 10.1016/j.yjmcc.2012.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2012.01.010</ArticleId><ArticleId IdType="pubmed">22285721</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncker D.J., Bache R.J. Regulation of coronary blood flow during exercise. Physiol. Rev. 2008;88:1009&#x2013;1086. doi: 10.1152/physrev.00045.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00045.2006</ArticleId><ArticleId IdType="pubmed">18626066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassenge E., Heusch G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev. Physiol. Biochem. Pharmacol. 1990;116:77&#x2013;165. doi: 10.1007/3540528806_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/3540528806_4</ArticleId><ArticleId IdType="pubmed">2293307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler W.H., Goresky C.A. Transcapillary exchange in the working left ventricle of the dog. Circ. Res. 1971;29:181&#x2013;207. doi: 10.1161/01.RES.29.2.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.29.2.181</ArticleId><ArticleId IdType="pubmed">4935840</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Zhao Q., Kong W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 2018;68&#x2013;69:490&#x2013;506. doi: 10.1016/j.matbio.2018.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2018.01.013</ArticleId><ArticleId IdType="pubmed">29371055</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N.G. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure. Circ. Res. 2019;125:117&#x2013;146. doi: 10.1161/CIRCRESAHA.119.311148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.119.311148</ArticleId><ArticleId IdType="pmc">PMC6588179</ArticleId><ArticleId IdType="pubmed">31219741</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber K.T. Cardiac interstitium in health and disease: The fibrillar collagen network. J. Am. Coll. Cardiol. 1989;13:1637&#x2013;1652. doi: 10.1016/0735-1097(89)90360-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(89)90360-4</ArticleId><ArticleId IdType="pubmed">2656824</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiente-Alandi I., Schafer A.E., Blaxall B.C. Extracellular matrix-mediated cellular communication in the heart. J. Mol. Cell. Cardiol. 2016;91:228. doi: 10.1016/j.yjmcc.2016.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2016.01.011</ArticleId><ArticleId IdType="pmc">PMC4767504</ArticleId><ArticleId IdType="pubmed">26778458</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kofahi M., Omura S., Tsunoda I., Sato F., Becker F., Gavins F.N.E., Woolard M.D., Pattillo C., Zawieja D., Muthuchamy M., et al. IL-1&#x3b2; reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis. Biomed. Pharmacother. 2018;107:1591&#x2013;1600. doi: 10.1016/j.biopha.2018.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.08.004</ArticleId><ArticleId IdType="pubmed">30257377</ArticleId></ArticleIdList></Reference><Reference><Citation>Abassi Z., Khoury E.E., Karram T., Aronson D. Edema formation in congestive heart failure and the underlying mechanisms. Front. Cardiovasc. Med. 2022;9:933215. doi: 10.3389/fcvm.2022.933215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.933215</ArticleId><ArticleId IdType="pmc">PMC9553007</ArticleId><ArticleId IdType="pubmed">36237903</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis K.L., Laine G.A., Geissler H.J., Mehlhorn U., Brennan M., Allen S.J. Effects of myocardial edema on the development of myocardial interstitial fibrosis. Microcirculation. 2000;7:269&#x2013;280. doi: 10.1111/j.1549-8719.2000.tb00127.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1549-8719.2000.tb00127.x</ArticleId><ArticleId IdType="pubmed">10963632</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heerebeek L., Hamdani N., Handoko M.L., Falcao-Pires I., Musters R.J., Kupreishvili K., Ijsselmuiden A.J.J., Schalkwijk C.G., Bronzwaer J.G.F., Diamant M., et al. Diastolic stiffness of the failing diabetic heart: Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117:43&#x2013;51. doi: 10.1161/CIRCULATIONAHA.107.728550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.728550</ArticleId><ArticleId IdType="pubmed">18071071</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heerebeek L., Borb&#xe9;ly A., Niessen H.W.M., Bronzwaer J.G.F., Van Der Velden J., Stienen G.J.M., Linke W.A., Laarman G.J., Paulus W.J. Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure. Circulation. 2006;113:1966&#x2013;1973. doi: 10.1161/CIRCULATIONAHA.105.587519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.587519</ArticleId><ArticleId IdType="pubmed">16618817</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser D.D., Patterson E.K., Slessarev M., Gill S.E., Martin C., Daley M., Miller M.R., Patel M.A., dos Santos C.C., Bosma K.J., et al. Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation. Crit. Care Explor. 2020;2:e0194. doi: 10.1097/CCE.0000000000000194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000194</ArticleId><ArticleId IdType="pmc">PMC7449254</ArticleId><ArticleId IdType="pubmed">32904031</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapkiewicz A.V., Mai X., Carsons S.E., Pittaluga S., Kleiner D.E., Berger J.S., Thomas S., Adler N.M., Charytan D.M., Gasmi B., et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine. 2020;24:100434. doi: 10.1016/j.eclinm.2020.100434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100434</ArticleId><ArticleId IdType="pmc">PMC7316051</ArticleId><ArticleId IdType="pubmed">32766543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz L., Capodanno D., Montalescot G., Angiolillo D.J. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J. Am. Heart Assoc. 2021;10:e019650. doi: 10.1161/JAHA.120.019650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019650</ArticleId><ArticleId IdType="pmc">PMC7955431</ArticleId><ArticleId IdType="pubmed">33228447</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 2020;13:120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Starling E.H. On the Absorption of Fluids from the Connective Tissue Spaces. J. Physiol. 1896;19:312&#x2013;326. doi: 10.1113/jphysiol.1896.sp000596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1896.sp000596</ArticleId><ArticleId IdType="pmc">PMC1512609</ArticleId><ArticleId IdType="pubmed">16992325</ArticleId></ArticleIdList></Reference><Reference><Citation>Levick J.R., Michel C.C. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 2010;87:198&#x2013;210. doi: 10.1093/cvr/cvq062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvq062</ArticleId><ArticleId IdType="pubmed">20200043</ArticleId></ArticleIdList></Reference><Reference><Citation>Staverman A.J. The theory of measurement of osmotic pressure. Recl. Des Trav. Chim. Des Pays-Bas. 1951;70:344&#x2013;352. doi: 10.1002/recl.19510700409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/recl.19510700409</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel C.C. Handbook of Physiology. The Cardiovascular System Microcirculation, Section 2. Volume 4. American Physiology Society; Bethesda, MD, USA: 1984. Fluid movements through capillary walls; pp. 375&#x2013;409.</Citation></Reference><Reference><Citation>Chilian W.M., Eastham C.L., Layne S.M., Marcus M.L. Small vessel phenomena in the coronary microcirculation: Phasic intramyocardial perfusion and coronary microvascular dynamics. Prog. Cardiovasc. Dis. 1988;31:17&#x2013;38. doi: 10.1016/0033-0620(88)90009-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0033-0620(88)90009-6</ArticleId><ArticleId IdType="pubmed">3293118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassingthwaighte J.B. A concurrent flow model for extraction during transcapillary passage. Circ. Res. 1974;35:483&#x2013;503. doi: 10.1161/01.RES.35.3.483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.35.3.483</ArticleId><ArticleId IdType="pmc">PMC3077802</ArticleId><ArticleId IdType="pubmed">4608628</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilian W.M. Microvascular pressures and resistances in the left ventricular subepicardium and subendocardium. Circ. Res. 1991;69:561&#x2013;570. doi: 10.1161/01.RES.69.3.561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.69.3.561</ArticleId><ArticleId IdType="pubmed">1873859</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama T., Kikuchi Y., Kakiuchi Y., Nagashima C. An analysis of water movement between myocardial tissue and capillary blood during reactive hyperemia. Jpn. J. Physiol. 1979;29:1&#x2013;13. doi: 10.2170/jjphysiol.29.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.2170/jjphysiol.29.1</ArticleId><ArticleId IdType="pubmed">449120</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine G.A., Granger H.J. Microvascular, interstitial, and lymphatic interactions in normal heart. Am. J. Physiol. 1985;249:H834&#x2013;H842. doi: 10.1152/ajpheart.1985.249.4.H834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1985.249.4.H834</ArticleId><ArticleId IdType="pubmed">4051019</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Marzilli M., Sabbah H.N., Lee T. Systolic and diastolic pressure gradients within the left ventricular wall. Am. J. Physiol. 1980;238:H625&#x2013;H630. doi: 10.1152/ajpheart.1980.238.5.H625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1980.238.5.H625</ArticleId><ArticleId IdType="pubmed">7377358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilati C.F. Macromolecular transport in canine coronary microvasculature. Am. J. Physiol. 1990;258:H748&#x2013;H753. doi: 10.1152/ajpheart.1990.258.3.H748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1990.258.3.H748</ArticleId><ArticleId IdType="pubmed">2316690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehlhorn U., Davis K.L., Laine G.A., Geissler H.J., Allen S.J. Myocardial fluid balance in acute hypertension. Microcirculation. 1996;3:371&#x2013;378. doi: 10.3109/10739689609148309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10739689609148309</ArticleId><ArticleId IdType="pubmed">9086448</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehlhorn U., Allen S.J., Davis K.L., Geissler H.J., Warters R.D., Rainer de Vivie E. Increasing the colloid osmotic pressure of cardiopulmonary bypass prime and normothermic blood cardioplegia minimizes myocardial oedema and prevents cardiac dysfunction. Cardiovasc. Surg. 1998;6:274&#x2013;281. doi: 10.1016/S0967-2109(97)00152-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0967-2109(97)00152-X</ArticleId><ArticleId IdType="pubmed">9705100</ArticleId></ArticleIdList></Reference><Reference><Citation>Navar P.D., Navar L.G. Relationship between colloid osmotic pressure and plasma protein concentration in the dog. Am. J. Physiol. 1977;233:H295&#x2013;H298. doi: 10.1152/ajpheart.1977.233.2.H295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1977.233.2.H295</ArticleId><ArticleId IdType="pubmed">888972</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry F.E., Michel C.C. The Colloid Osmotic Pressure Across the Glycocalyx: Role of Interstitial Fluid Sub-Compartments in Trans-Vascular Fluid Exchange in Skeletal Muscle. Front. Cell Dev. Biol. 2021;9:729873. doi: 10.3389/fcell.2021.729873.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.729873</ArticleId><ArticleId IdType="pmc">PMC8397480</ArticleId><ArticleId IdType="pubmed">34458277</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer P.S., Levick J.R. Chronic peripheral oedema: The critical role of the lymphatic system. Clin. Med. 2004;4:448&#x2013;453. doi: 10.7861/clinmedicine.4-5-448.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.4-5-448</ArticleId><ArticleId IdType="pmc">PMC5351904</ArticleId><ArticleId IdType="pubmed">15536876</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma S., Slaaf D.W., Vink H., Van Zandvoort M.A., Egbrink M.G.A.O. The endothelial glycocalyx: Composition, functions, and visualization. Pflug. Arch. Eur. J. Physiol. 2007;454:345&#x2013;359. doi: 10.1007/s00424-007-0212-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-007-0212-8</ArticleId><ArticleId IdType="pmc">PMC1915585</ArticleId><ArticleId IdType="pubmed">17256154</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink H., Duling B.R. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am. J. Physiol. Heart Circ. Physiol. 2000;278:H285&#x2013;H289. doi: 10.1152/ajpheart.2000.278.1.H285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2000.278.1.H285</ArticleId><ArticleId IdType="pubmed">10644610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ori A., Wilkinson M.C., Fernig D.G. A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome. J. Biol. Chem. 2011;286:19892. doi: 10.1074/jbc.M111.228114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.228114</ArticleId><ArticleId IdType="pmc">PMC3103365</ArticleId><ArticleId IdType="pubmed">21454685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiig H., Swartz M.A. Interstitial fluid and lymph formation and transport: Physiological regulation and roles in inflammation and cancer. Physiol. Rev. 2012;92:1005&#x2013;1060. doi: 10.1152/physrev.00037.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00037.2011</ArticleId><ArticleId IdType="pubmed">22811424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wearn J.T. The extent of the capillary bed of the heart. J. Exp. Med. 1928;47:273&#x2013;290. doi: 10.1084/jem.47.2.273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.47.2.273</ArticleId><ArticleId IdType="pmc">PMC2131359</ArticleId><ArticleId IdType="pubmed">19869413</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine G.A. Microvascular changes in the heart during chronic arterial hypertension. Circ. Res. 1988;62:953&#x2013;960. doi: 10.1161/01.RES.62.5.953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.62.5.953</ArticleId><ArticleId IdType="pubmed">3359578</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbrugge F.H., Bertrand P.B., Willems E., Gielen E., Mullens W., Giri S., Tang W.H.W., Raman S.V., Verhaert D. Global myocardial oedema in advanced decompensated heart failure. Eur. Heart J. Cardiovasc. Imaging. 2017;18:787&#x2013;794. doi: 10.1093/ehjci/jew131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jew131</ArticleId><ArticleId IdType="pubmed">27378769</ArticleId></ArticleIdList></Reference><Reference><Citation>Takegawa R., Kabata D., Shimizu K., Hisano S., Ogura H., Shintani A., Shimazu T. Serum albumin as a risk factor for death in patients with prolonged sepsis: An observational study. J. Crit. Care. 2019;51:139&#x2013;144. doi: 10.1016/j.jcrc.2019.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2019.02.004</ArticleId><ArticleId IdType="pubmed">30825787</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd J.H., Forbes J., Nakada T.A., Walley K.R., Russell J.A. Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit. Care Med. 2011;39:259&#x2013;265. doi: 10.1097/CCM.0b013e3181feeb15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181feeb15</ArticleId><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiig H., Rubin K., Reed R.K. New and active role of the interstitium in control of interstitial fluid pressure: Potential therapeutic consequences. Acta Anaesthesiol. Scand. 2003;47:111&#x2013;121. doi: 10.1034/j.1399-6576.2003.00050.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2003.00050.x</ArticleId><ArticleId IdType="pubmed">12631039</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 2007;9:121&#x2013;167. doi: 10.1146/annurev.bioeng.9.060906.151959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bioeng.9.060906.151959</ArticleId><ArticleId IdType="pubmed">17373886</ArticleId></ArticleIdList></Reference><Reference><Citation>Squire J.M., Chew M., Nneji G., Neal C., Barry J., Michel C. Quasi-periodic substructure in the microvessel endothelial glycocalyx: A possible explanation for molecular filtering? J. Struct. Biol. 2001;136:239&#x2013;255. doi: 10.1006/jsbi.2002.4441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.2002.4441</ArticleId><ArticleId IdType="pubmed">12051903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostgaard J., Qvortrup K. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc. Res. 1997;53:1&#x2013;13. doi: 10.1006/mvre.1996.1987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mvre.1996.1987</ArticleId><ArticleId IdType="pubmed">9056471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarbell J.M., Cancel L.M. The glycocalyx and its significance in human medicine. J. Intern. Med. 2016;280:97&#x2013;113. doi: 10.1111/joim.12465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12465</ArticleId><ArticleId IdType="pubmed">26749537</ArticleId></ArticleIdList></Reference><Reference><Citation>Pries A.R., Secomb T.W., Gaehtgens P. The endothelial surface layer. Pflug. Arch. 2000;440:653&#x2013;666. doi: 10.1007/s004240000307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004240000307</ArticleId><ArticleId IdType="pubmed">11007304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipowsky H.H. Microvascular rheology and hemodynamics. Microcirculation. 2005;12:5&#x2013;15. doi: 10.1080/10739680590894966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10739680590894966</ArticleId><ArticleId IdType="pubmed">15804970</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink H., Constantinescu A.A., Spaan J.A.E. Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet-endothelial cell adhesion. Circulation. 2000;101:1500&#x2013;1502. doi: 10.1161/01.CIR.101.13.1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.13.1500</ArticleId><ArticleId IdType="pubmed">10747340</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta D., Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 2006;86:279&#x2013;367. doi: 10.1152/physrev.00012.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00012.2005</ArticleId><ArticleId IdType="pubmed">16371600</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch B., Ljungman C., Heldin C.M., Waskson E., &#xd6;brink B. Surface properties of cultured endothelial cells. Haemostasis. 1979;8:142&#x2013;148. doi: 10.1159/000214306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000214306</ArticleId><ArticleId IdType="pubmed">389754</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano E.R. The effect of the endothelial-cell glycocalyx on the motion of red blood cells through capillaries. Microvasc. Res. 1998;55:77&#x2013;91. doi: 10.1006/mvre.1997.2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mvre.1997.2052</ArticleId><ArticleId IdType="pubmed">9473411</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamson R.H., Huxley V.H., Curry F.E. Single capillary permeability to proteins having similar size but different charge. Am. J. Physiol. 1988;254:H304&#x2013;H312. doi: 10.1152/ajpheart.1988.254.2.H304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1988.254.2.H304</ArticleId><ArticleId IdType="pubmed">3257846</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry C.B.S., Duling B.R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol. 1999;277:H508&#x2013;H514. doi: 10.1152/ajpheart.1999.277.2.H508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1999.277.2.H508</ArticleId><ArticleId IdType="pubmed">10444475</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamson R.H. Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J. Physiol. 1990;428:1&#x2013;13. doi: 10.1113/jphysiol.1990.sp018197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1990.sp018197</ArticleId><ArticleId IdType="pmc">PMC1181632</ArticleId><ArticleId IdType="pubmed">2231409</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers M.R., Blumenstock F.A., Cooper J.A., Malik A.B. Role of albumin arginyl sites in albumin-induced reduction of endothelial hydraulic conductivity. J. Cell. Physiol. 1989;141:558&#x2013;564. doi: 10.1002/jcp.1041410314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.1041410314</ArticleId><ArticleId IdType="pubmed">2512305</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeberger E.E., Hamelin M. Interaction of serum proteins with lung endothelial glycocalyx: Its effect on endothelial permeability. Am. J. Physiol. 1984;247:H206&#x2013;H217. doi: 10.1152/ajpheart.1984.247.2.H206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1984.247.2.H206</ArticleId><ArticleId IdType="pubmed">6465329</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Clough G., Michel C.C. The effects of cationised ferritin and native ferritin upon the filtration coefficient of single frog capillaries. Evidence that proteins in the endothelial cell coat influence permeability. Microvasc. Res. 1983;25:205&#x2013;222. doi: 10.1016/0026-2862(83)90016-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-2862(83)90016-X</ArticleId><ArticleId IdType="pubmed">6843373</ArticleId></ArticleIdList></Reference><Reference><Citation>Levick J.R., Michel C.C. The effect of bovine albumin on the permeability of frog mesenteric capillaries. Q. J. Exp. Physiol. Cogn. Med. Sci. 1973;58:87&#x2013;97. doi: 10.1113/expphysiol.1973.sp002194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.1973.sp002194</ArticleId><ArticleId IdType="pubmed">4540065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Quintero S.V., Amaya R., Pahakis M., Tarbell J.M. The endothelial glycocalyx mediates shear-induced changes in hydraulic conductivity. Am. J. Physiol. Circ. Physiol. 2009;296:H1451&#x2013;H1456. doi: 10.1152/ajpheart.00894.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00894.2008</ArticleId><ArticleId IdType="pmc">PMC2685345</ArticleId><ArticleId IdType="pubmed">19286951</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob M., Rehm M., Loetsch M., Paul J.O., Bruegger D., Welsch U., Conzen P., Becker B.F. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J. Vasc. Res. 2007;44:435&#x2013;443. doi: 10.1159/000104871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000104871</ArticleId><ArticleId IdType="pubmed">17622736</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Bolli R., Qiu Y., Tang X.L., Murphree S.S., French B.A. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation. 1998;98:1438&#x2013;1448. doi: 10.1161/01.CIR.98.14.1438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.14.1438</ArticleId><ArticleId IdType="pubmed">9760299</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada K., Kobayashi M., Kimura S., Nishinaga M., Takeuchi K., Ozawa T., Shimada K., Kobayashi M., Kimura S., Nishinaga M., et al. Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface. Jpn. Circ. J. 1991;55:1016&#x2013;1021. doi: 10.1253/jcj.55.1016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/jcj.55.1016</ArticleId><ArticleId IdType="pubmed">1744977</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar A.M.F., De Mattos D.A., Stelling M.P., Sarcinelli-Luz B.S.L., Nazareth R.A., Mour&#xe3;o P.A.S. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: Implications for a possible physiological function of heparin cofactor II. Biochim. Biophys. Acta. 2005;1740:45&#x2013;53. doi: 10.1016/j.bbadis.2005.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2005.02.008</ArticleId><ArticleId IdType="pubmed">15878740</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson E.K., Cepinskas G., Fraser D.D. Endothelial Glycocalyx Degradation in Critical Illness and Injury. Front. Med. 2022;9:898592. doi: 10.3389/fmed.2022.898592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.898592</ArticleId><ArticleId IdType="pmc">PMC9304628</ArticleId><ArticleId IdType="pubmed">35872762</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berg B.M., Vink H., Spaan J.A.E. The Endothelial Glycocalyx Protects Against Myocardial Edema. Circ. Res. 2003;92:592&#x2013;594. doi: 10.1161/01.RES.0000065917.53950.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000065917.53950.75</ArticleId><ArticleId IdType="pubmed">12637366</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob M., Bruegger D., Rehm M., Welsch U., Conzen P., Becker B.F. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006;104:1223&#x2013;1231. doi: 10.1097/00000542-200606000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200606000-00018</ArticleId><ArticleId IdType="pubmed">16732094</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A.B., Siflinger-Birnboim A. Biological Barriers to Protein Delivery. Springer; Boston, MA, USA: 1993. Vascular Endothelial Barrier Function and Its Regulation; pp. 231&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-2898-2_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann G.E. Alterations of myocardial capillary permeability by albumin in the isolated, perfused rabbit heart. J. Physiol. 1981;319:311&#x2013;323. doi: 10.1113/jphysiol.1981.sp013910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1981.sp013910</ArticleId><ArticleId IdType="pmc">PMC1243840</ArticleId><ArticleId IdType="pubmed">6798198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesinger A., Peters W., Chappell D., Kentrup D., Reuter S., Pavenst&#xe4;dt H., Oberleithner H., K&#xfc;mpers P. Nanomechanics of the Endothelial Glycocalyx in Experimental Sepsis. PLoS ONE. 2013;8:e80905. doi: 10.1371/journal.pone.0080905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080905</ArticleId><ArticleId IdType="pmc">PMC3835794</ArticleId><ArticleId IdType="pubmed">24278345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rienks M., Carai P., van Teeffelen J., Eskens B., Verhesen W., Hemmeryckx B., Johnson D.M., van Leeuwen R., Jones E.A., Heymans S., et al. SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis. Matrix Biol. 2018;74:21&#x2013;34. doi: 10.1016/j.matbio.2018.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2018.04.015</ArticleId><ArticleId IdType="pubmed">29730504</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein F.H., Parrillo J.E. Pathogenetic Mechanisms of Septic Shock. N. Engl. J. Med. 1993;328:1471&#x2013;1477. doi: 10.1056/NEJM199305203282008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199305203282008</ArticleId><ArticleId IdType="pubmed">8479467</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T.H.C., Alonso S., Ng L.F.P., Thein T.L., Pang V.J.X., Leo Y.S., Lye D.C.B., Yeo T.W. Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity. Sci. Rep. 2017;7:srep46191. doi: 10.1038/srep46191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46191</ArticleId><ArticleId IdType="pmc">PMC5385535</ArticleId><ArticleId IdType="pubmed">28393899</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H., Glasner D.R., Harris E. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability. PLoS Pathog. 2016;12:e1005738. doi: 10.1371/journal.ppat.1005738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005738</ArticleId><ArticleId IdType="pmc">PMC4944995</ArticleId><ArticleId IdType="pubmed">27416066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansch P., Nelson A., Ohlsson T., Bentzer P. Effect of charge on microvascular permeability in early experimental sepsis in the rat. Microvasc. Res. 2011;82:339&#x2013;345. doi: 10.1016/j.mvr.2011.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2011.08.008</ArticleId><ArticleId IdType="pubmed">21906604</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry C.B.S., Duling B.R. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 2000;279:H2815&#x2013;H2823. doi: 10.1152/ajpheart.2000.279.6.H2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2000.279.6.H2815</ArticleId><ArticleId IdType="pubmed">11087236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley K., Tedder T.F. Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling. J. Immunol. 1995;155:525&#x2013;528. doi: 10.4049/jimmunol.155.2.525.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.155.2.525</ArticleId><ArticleId IdType="pubmed">7541818</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson M.W., Stone P., Shasby D.M. Cationic neutrophil proteins increase transendothelial albumin movement. J. Appl. Physiol. 1987;62:1521&#x2013;1530. doi: 10.1152/jappl.1987.62.4.1521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1987.62.4.1521</ArticleId><ArticleId IdType="pubmed">3648023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover R.L., Briggs R.T., Karnovsky M.J. The adhesive interaction between polymorphonuclear leukocytes and endothelial cells in vitro. Cell. 1978;14:423&#x2013;428. doi: 10.1016/0092-8674(78)90127-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(78)90127-7</ArticleId><ArticleId IdType="pubmed">667949</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita Y., Clemens M.G., Miller L.S., Rangan U., Kondo S., Miyasaka M., Yoshikawa T., Bulkley G.B. Reactive oxidants mediate TNF-alpha-induced leukocyte adhesion to rat mesenteric venular endothelium. Am. J. Physiol. 1995;269:H1833&#x2013;H1842. doi: 10.1152/ajpheart.1995.269.6.H1833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1995.269.6.H1833</ArticleId><ArticleId IdType="pubmed">8594890</ArticleId></ArticleIdList></Reference><Reference><Citation>Carden D.L., Smith J.K., Korthuis R.J. Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Role of granulocyte adherence. Circ. Res. 1990;66:1436&#x2013;1444. doi: 10.1161/01.RES.66.5.1436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.66.5.1436</ArticleId><ArticleId IdType="pubmed">2159391</ArticleId></ArticleIdList></Reference><Reference><Citation>Radeva M.Y., Waschke J. Mind the gap: Mechanisms regulating the endothelial barrier. Acta Physiol. 2018;222:e12860. doi: 10.1111/apha.12860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12860</ArticleId><ArticleId IdType="pubmed">28231640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward B.J., Donnelly J.L. Hypoxia induced disruption of the cardiac endothelial glycocalyx: Implications for capillary permeability. Cardiovasc. Res. 1993;27:384&#x2013;389. doi: 10.1093/cvr/27.3.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/27.3.384</ArticleId><ArticleId IdType="pubmed">7683973</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu A.A., Vink H., Spaan J.A.E. Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am. J. Physiol. Heart Circ. Physiol. 2001;280:H1051&#x2013;H1057. doi: 10.1152/ajpheart.2001.280.3.H1051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2001.280.3.H1051</ArticleId><ArticleId IdType="pubmed">11179046</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner G., Banka C.L., Roberts K.A., Mullick A.E., Rutledge J.C. Modified LDL&#x2013;Mediated Increases in Endothelial Layer Permeability Are Attenuated with 17&#x3b2;-Estradiol. Arter. Thromb. Vasc. Biol. 1999;19:854&#x2013;861. doi: 10.1161/01.ATV.19.4.854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.19.4.854</ArticleId><ArticleId IdType="pubmed">10195909</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaswamy S., Penn M.S., Saidel G.M., Chisolm G.M. Exogenous Oxidized Low-Density Lipoprotein Injures and Alters the Barrier Function of Endothelium in Rats In Vivo. Circ. Res. 1997;80:37&#x2013;44. doi: 10.1161/01.RES.80.1.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.80.1.37</ArticleId><ArticleId IdType="pubmed">8978320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehr H.A., Frei B., Olofsson A.M., Carew T.E., Arfors K.E. Protection From Oxidized LDL&#x2013;Induced Leukocyte Adhesion to Microvascular and Macrovascular Endothelium In Vivo by Vitamin C but Not by Vitamin E. Circulation. 1995;91:1525&#x2013;1532. doi: 10.1161/01.CIR.91.5.1525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.91.5.1525</ArticleId><ArticleId IdType="pubmed">7867194</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao L., Harris N.R., Granger D.N. Oxidized low-density lipoproteins and microvascular responses to ischemia-reperfusion. Am. J. Physiol. Circ. Physiol. 1996;271:H2508&#x2013;H2514. doi: 10.1152/ajpheart.1996.271.6.H2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1996.271.6.H2508</ArticleId><ArticleId IdType="pubmed">8997311</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehr H.A., Becker M., Marklund S.L., H&#xfc;bner C., Arfors K.E., Kohlsch&#xfc;tter A., Messmer K. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arter. Thromb. A J. Vasc. Biol. 1992;12:824&#x2013;829. doi: 10.1161/01.ATV.12.7.824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.12.7.824</ArticleId><ArticleId IdType="pubmed">1616907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ber&#x119;sewicz A., Czarnowska E., M&#x105;czewski M. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts. Myocard. Ischemia Reper. 1998:87&#x2013;97. doi: 10.1007/978-1-4615-4979-6_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-4979-6_11</ArticleId><ArticleId IdType="pubmed">9774189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulivor A.W., Lipowsky H.H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 2004;286:H1672&#x2013;H1680. doi: 10.1152/ajpheart.00832.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00832.2003</ArticleId><ArticleId IdType="pubmed">14704229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurzelewski M., Czarnowska E., Beresewicz A. Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J. Physiol. Pharmacol. 2005;56:163&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">15985700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Kalogeris T., Korthuis R.J. Reactive species-induced microvascular dysfunction in ischemia/reperfusion. Free Radic. Biol. Med. 2019;135:182&#x2013;197. doi: 10.1016/j.freeradbiomed.2019.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.02.031</ArticleId><ArticleId IdType="pmc">PMC6503659</ArticleId><ArticleId IdType="pubmed">30849489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalogeris T., Baines C.P., Krenz M., Korthuis R.J. Ischemia/Reperfusion. Compr. Physiol. 2016;7:113&#x2013;170. doi: 10.1002/cphy.c160006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c160006</ArticleId><ArticleId IdType="pmc">PMC5648017</ArticleId><ArticleId IdType="pubmed">28135002</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Xu W., Zhou R. NLRP3 inflammasome activation and cell death. Cell. Mol. Immunol. 2021;18:2114&#x2013;2127. doi: 10.1038/s41423-021-00740-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00740-6</ArticleId><ArticleId IdType="pmc">PMC8429580</ArticleId><ArticleId IdType="pubmed">34321623</ArticleId></ArticleIdList></Reference><Reference><Citation>Poledniczek M., Neumayer C., Kopp C.W., Schlager O., Gremmel T., Jozkowicz A., Gschwandtner M.E., Koppensteiner R., Wadowski P.P. Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease&#x2014;Pathophysiology and Translational Therapeutic Approaches. Biomedicines. 2023;11:2284. doi: 10.3390/biomedicines11082284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082284</ArticleId><ArticleId IdType="pmc">PMC10452462</ArticleId><ArticleId IdType="pubmed">37626780</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli M., Niccoli G., De Maria G., Brugaletta S., Montone R.A., Vergallo R., Benenati S., Magniani G., D&#x2019;Amario D., Porto I., et al. Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nat. Rev. Cardiol. 2023;2023:1&#x2013;16. doi: 10.1038/s41569-023-00953-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00953-4</ArticleId><ArticleId IdType="pubmed">38001231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski S.R., Pedersen S.H., Jensen J.S., Mogelvang R., Johansson P.I. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit. Care. 2013;17:R32. doi: 10.1186/cc12532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12532</ArticleId><ArticleId IdType="pmc">PMC4057225</ArticleId><ArticleId IdType="pubmed">23433357</ArticleId></ArticleIdList></Reference><Reference><Citation>Algoet M., Janssens S., Himmelreich U., Gsell W., Pusovnik M., Van den Eynde J., Oosterlinck W. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc. Med. 2023;33:357&#x2013;366. doi: 10.1016/j.tcm.2022.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2022.02.005</ArticleId><ArticleId IdType="pubmed">35181472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini D., Kawakami R., Guagliumi G., Sakamoto A., Kawai K., Gianatti A., Nasr A., Kutys R., Guo L., Cornelissen A., et al. Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. Circulation. 2021;143:1031&#x2013;1042. doi: 10.1161/CIRCULATIONAHA.120.051828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051828</ArticleId><ArticleId IdType="pubmed">33480806</ArticleId></ArticleIdList></Reference><Reference><Citation>Reffelmann T., Kloner R.A. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res. Cardiol. 2006;101:359&#x2013;372. doi: 10.1007/s00395-006-0615-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-006-0615-2</ArticleId><ArticleId IdType="pubmed">16915531</ArticleId></ArticleIdList></Reference><Reference><Citation>Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 2020;17:773&#x2013;789. doi: 10.1038/s41569-020-0403-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0403-y</ArticleId><ArticleId IdType="pubmed">32620851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekkers S.C.A.M., Yazdani S.K., Virmani R., Waltenberger J. Microvascular Obstruction: Underlying Pathophysiology and Clinical Diagnosis. J. Am. Coll. Cardiol. 2010;55:1649&#x2013;1660. doi: 10.1016/j.jacc.2009.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.12.037</ArticleId><ArticleId IdType="pubmed">20394867</ArticleId></ArticleIdList></Reference><Reference><Citation>Crea F., Montone R.A., Rinaldi R. Pathophysiology of Coronary Microvascular Dysfunction. Circ. J. 2022;86:1319&#x2013;1328. doi: 10.1253/circj.CJ-21-0848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-21-0848</ArticleId><ArticleId IdType="pubmed">34759123</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzer B., Kopp C.W., Neumayer C., Koppensteiner R., Jozkowicz A., Poledniczek M., Gremmel T., Jilma B., Wadowski P.P. Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review. Cells. 2023;12:1865. doi: 10.3390/cells12141865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12141865</ArticleId><ArticleId IdType="pmc">PMC10377790</ArticleId><ArticleId IdType="pubmed">37508529</ArticleId></ArticleIdList></Reference><Reference><Citation>Guagliumi G., Sonzogni A., Pescetelli I., Pellegrini D., Finn A.V. Microthrombi and ST-Segment-Elevation Myocardial Infarction in COVID-19. Circulation. 2020;142:804&#x2013;809. doi: 10.1161/CIRCULATIONAHA.120.049294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049294</ArticleId><ArticleId IdType="pmc">PMC7439756</ArticleId><ArticleId IdType="pubmed">32677840</ArticleId></ArticleIdList></Reference><Reference><Citation>Montone R.A., Iannaccone G., Meucci M.C., Gurgoglione F., Niccoli G. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019. Eur. Cardiol. 2020;15:e52. doi: 10.15420/ecr.2020.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2020.22</ArticleId><ArticleId IdType="pmc">PMC7325215</ArticleId><ArticleId IdType="pubmed">32617121</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003;9:653&#x2013;660. doi: 10.1038/nm0603-653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0603-653</ArticleId><ArticleId IdType="pubmed">12778163</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242&#x2013;248. doi: 10.1038/35025215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35025215</ArticleId><ArticleId IdType="pubmed">11001067</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverini P.J. The pathophysiology of angiogenesis. Crit. Rev. Oral Biol. Med. 1995;6:230&#x2013;247. doi: 10.1177/10454411950060030501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10454411950060030501</ArticleId><ArticleId IdType="pubmed">8785263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimna A., Kurpisz M. Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies. Biomed Res. Int. 2015;2015:549412. doi: 10.1155/2015/549412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/549412</ArticleId><ArticleId IdType="pmc">PMC4471260</ArticleId><ArticleId IdType="pubmed">26146622</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliceiri B.P., Paul R., Schwartzberg P.L., Hood J.D., Leng J., Cheresh D.A. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell. 1999;4:915&#x2013;924. doi: 10.1016/S1097-2765(00)80221-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80221-X</ArticleId><ArticleId IdType="pubmed">10635317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson A.R., Fingleton B., Rothenberg M.L., Matrisian L.M. Matrix metalloproteinases: Biologic activity and clinical implications. J. Clin. Oncol. 2000;18:1135&#x2013;1149. doi: 10.1200/JCO.2000.18.5.1135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2000.18.5.1135</ArticleId><ArticleId IdType="pubmed">10694567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Yosef Y., Miller A., Shapiro S., Lahat N. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am. J. Physiol. Cell Physiol. 2005;289:C1321&#x2013;C1331. doi: 10.1152/ajpcell.00079.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00079.2005</ArticleId><ArticleId IdType="pubmed">16210427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Singh P., Shami A., Kluza E., Pan M., Djordjevic D., Michaelsen N.B., Kennb&#xe4;ck C., van der Wel N.N., Orho-Melander M., et al. Spatial Transcriptional Mapping Reveals Site-Specific Pathways Underlying Human Atherosclerotic Plaque Rupture. J. Am. Coll. Cardiol. 2023;81:2213&#x2013;2227. doi: 10.1016/j.jacc.2023.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.04.008</ArticleId><ArticleId IdType="pubmed">37286250</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetze J.P., Bruneau B.G., Ramos H.R., Ogawa T., de Bold M.K., de Bold A.J. Cardiac natriuretic peptides. Nat. Rev. Cardiol. 2020;17:698&#x2013;717. doi: 10.1038/s41569-020-0381-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0381-0</ArticleId><ArticleId IdType="pubmed">32444692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando S.I., Imaizumi T., Harada S., Hirooka Y., Takeshita A. Atrial natriuretic peptide increases human capillary filtration and venous distensibility. J. Hypertens. 1992;10:451&#x2013;457. doi: 10.1097/00004872-199205000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004872-199205000-00008</ArticleId><ArticleId IdType="pubmed">1317906</ArticleId></ArticleIdList></Reference><Reference><Citation>Huxley V.H., Tucker V.L., Verburg K.M., Freeman R.H. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ. Res. 1987;60:304&#x2013;307. doi: 10.1161/01.RES.60.2.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.60.2.304</ArticleId><ArticleId IdType="pubmed">2952366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruegger D., Jacob M., Rehm M., Loetsch M., Welsch U., Conzen P., Becker B.F. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am. J. Physiol. Circ. Physiol. 2005;289:H1993&#x2013;H1999. doi: 10.1152/ajpheart.00218.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00218.2005</ArticleId><ArticleId IdType="pubmed">15964925</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob M., Saller T., Chappell D., Rehm M., Welsch U., Becker B.F. Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res. Cardiol. 2013;108:347. doi: 10.1007/s00395-013-0347-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-013-0347-z</ArticleId><ArticleId IdType="pubmed">23563917</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberleithner H., Peters W., Kusche-Vihrog K., Korte S., Schillers H., Kliche K., Oberleithner K. Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflug. Arch. 2011;462:519&#x2013;528. doi: 10.1007/s00424-011-0999-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-011-0999-1</ArticleId><ArticleId IdType="pmc">PMC3170475</ArticleId><ArticleId IdType="pubmed">21796337</ArticleId></ArticleIdList></Reference><Reference><Citation>Selcuk M., Keskin M., Cinar T., Gunay N., Dogan S., Cicek V., Kilic S., Asal S., Yavuz S., Keser N., et al. Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure. Eur. Heart J. 2021;42((Suppl. S1)):ehab724.0866. doi: 10.1093/eurheartj/ehab724.0866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab724.0866</ArticleId><ArticleId IdType="pmc">PMC8302897</ArticleId><ArticleId IdType="pubmed">34326968</ArticleId></ArticleIdList></Reference><Reference><Citation>Huelsmann M., Neuhold S., Resl M., Strunk G., Brath H., Francesconi C., Adlbrecht C., Prager R., Luger A., Pacher R., et al. PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease): A Prospective Randomized Controlled Trial. J. Am. Coll. Cardiol. 2013;62:1365&#x2013;1372. doi: 10.1016/j.jacc.2013.05.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.05.069</ArticleId><ArticleId IdType="pubmed">23810874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartsock A., Nelson W.J. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta-Biomembr. 2008;1778:660&#x2013;669. doi: 10.1016/j.bbamem.2007.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2007.07.012</ArticleId><ArticleId IdType="pmc">PMC2682436</ArticleId><ArticleId IdType="pubmed">17854762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano T., Torisawa T., Oiwa K., Tsukita S. AMPK-dependent phosphorylation of cingulin reversibly regulates its binding to actin filaments and microtubules. Sci. Rep. 2018;8:15550. doi: 10.1038/s41598-018-33418-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33418-7</ArticleId><ArticleId IdType="pmc">PMC6195624</ArticleId><ArticleId IdType="pubmed">30341325</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Mariscal L., Tapia R., Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim. Biophys. Acta. 2008;1778:729&#x2013;756. doi: 10.1016/j.bbamem.2007.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2007.08.018</ArticleId><ArticleId IdType="pubmed">17950242</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev. Cell. 2009;16:209&#x2013;221. doi: 10.1016/j.devcel.2009.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2009.01.004</ArticleId><ArticleId IdType="pubmed">19217423</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb. Perspect. Biol. 2010;2:a002907. doi: 10.1101/cshperspect.a002907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a002907</ArticleId><ArticleId IdType="pmc">PMC2827901</ArticleId><ArticleId IdType="pubmed">20182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemot L., Paschoud S., Pulimeno P., Foglia A., Citi S. The cytoplasmic plaque of tight junctions: A scaffolding and signalling center. Biochim. Biophys. Acta. 2008;1778:601&#x2013;613. doi: 10.1016/j.bbamem.2007.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2007.09.032</ArticleId><ArticleId IdType="pubmed">18339298</ArticleId></ArticleIdList></Reference><Reference><Citation>Schossleitner K., Rauscher S., Gr&#xf6;ger M., Friedl H.P., Finsterwalder R., Habertheuer A., Sibilia M., Brostjan C., F&#xf6;dinger D., Citi S., et al. Evidence That Cingulin Regulates Endothelial Barrier Function In Vitro and In Vivo. Arter. Thromb. Vasc. Biol. 2016;36:647&#x2013;654. doi: 10.1161/ATVBAHA.115.307032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.115.307032</ArticleId><ArticleId IdType="pubmed">26821949</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E., Vestweber D. The role of VE-cadherin in vascular morphogenesis and permeability control. Prog. Mol. Biol. Transl. Sci. 2013;116:119&#x2013;144. doi: 10.1016/B978-0-12-394311-8.00006-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-394311-8.00006-6</ArticleId><ArticleId IdType="pubmed">23481193</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravi L., Dejana E., Lampugnani M.G. VE-cadherin at a glance. Cell Tissue Res. 2014;355:515&#x2013;522. doi: 10.1007/s00441-014-1843-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-014-1843-7</ArticleId><ArticleId IdType="pubmed">24643676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavard J. Endothelial permeability and VE-cadherin: A wacky comradeship. Cell Adhes. Migr. 2014;8:158&#x2013;164. doi: 10.4161/cam.29026.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.29026</ArticleId><ArticleId IdType="pmc">PMC4049861</ArticleId><ArticleId IdType="pubmed">25422846</ArticleId></ArticleIdList></Reference><Reference><Citation>Waschke J., Curry F.E., Adamson R.H., Drenckhahn D. Regulation of actin dynamics is critical for endothelial barrier functions. Am. J. Physiol. Heart Circ. Physiol. 2005;288:H1296&#x2013;H1305. doi: 10.1152/ajpheart.00687.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00687.2004</ArticleId><ArticleId IdType="pubmed">15528228</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens T., Garcia J.G.N., Shasby D.M., Bhattacharya J., Malik A.B. Mechanisms regulating endothelial cell barrier function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000;279:L419&#x2013;L422. doi: 10.1152/ajplung.2000.279.3.L419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.2000.279.3.L419</ArticleId><ArticleId IdType="pubmed">10956614</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasain N., Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc. Res. 2009;77:53&#x2013;63. doi: 10.1016/j.mvr.2008.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2008.09.012</ArticleId><ArticleId IdType="pmc">PMC2700738</ArticleId><ArticleId IdType="pubmed">19028505</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudek S.M., Garcia J.G.N. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 2001;91:1487&#x2013;1500. doi: 10.1152/jappl.2001.91.4.1487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.2001.91.4.1487</ArticleId><ArticleId IdType="pubmed">11568129</ArticleId></ArticleIdList></Reference><Reference><Citation>Shasby D.M., Shasby S.S., Sullivan J.M., Peach M.J. Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ. Res. 1982;51:657&#x2013;661. doi: 10.1161/01.RES.51.5.657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.51.5.657</ArticleId><ArticleId IdType="pubmed">6890416</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Ponce A., Cital&#xe1;n-Madrid A.F., Vel&#xe1;zquez-Avila M., Vargas-Robles H., Schnoor M. The role of actin-binding proteins in the control of endothelial barrier integrity. Thromb. Haemost. 2015;113:20&#x2013;36. doi: 10.1160/TH14-04-0298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH14-04-0298</ArticleId><ArticleId IdType="pubmed">25183310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Dudek S.M. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc. Res. 2009;77:39&#x2013;45. doi: 10.1016/j.mvr.2008.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2008.09.005</ArticleId><ArticleId IdType="pmc">PMC2693384</ArticleId><ArticleId IdType="pubmed">18973762</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Waters C.L., Hu C., Wysolmerski R.B., Vincent P.A., Minnear F.L. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am. J. Physiol. Cell Physiol. 2007;293:C1309&#x2013;C1318. doi: 10.1152/ajpcell.00014.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00014.2007</ArticleId><ArticleId IdType="pubmed">17670896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkerson B.A., Argraves K.M. The role of sphingosine-1-phosphate in endothelial barrier function. Biochim. Biophys. Acta. 2014;1841:1403&#x2013;1412. doi: 10.1016/j.bbalip.2014.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2014.06.012</ArticleId><ArticleId IdType="pmc">PMC4169319</ArticleId><ArticleId IdType="pubmed">25009123</ArticleId></ArticleIdList></Reference><Reference><Citation>David S., Ghosh C.C., Mukherjee A., Parikh S.M. Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense. Arter. Thromb. Vasc. Biol. 2011;31:2643&#x2013;2652. doi: 10.1161/ATVBAHA.111.233189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.111.233189</ArticleId><ArticleId IdType="pmc">PMC3249617</ArticleId><ArticleId IdType="pubmed">21885850</ArticleId></ArticleIdList></Reference><Reference><Citation>Frye M., Dierkes M., K&#xfc;ppers V., Vockel M., Tomm J., Zeuschner D., Rossaint J., Zarbock A., Koh G.Y., Peters K., et al. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. J. Exp. Med. 2015;212:2267&#x2013;2287. doi: 10.1084/jem.20150718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150718</ArticleId><ArticleId IdType="pmc">PMC4689167</ArticleId><ArticleId IdType="pubmed">26642851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y., Adamson R.H., Curry F.R.E., Tarbell J.M. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am. J. Physiol. Heart Circ. Physiol. 2014;306:H363&#x2013;H372. doi: 10.1152/ajpheart.00687.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00687.2013</ArticleId><ArticleId IdType="pmc">PMC3920139</ArticleId><ArticleId IdType="pubmed">24285115</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel N., Waschke J. cAMP with other signaling cues converges on Rac1 to stabilize the endothelial barrier- a signaling pathway compromised in inflammation. Cell Tissue Res. 2014;355:587&#x2013;596. doi: 10.1007/s00441-013-1755-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-013-1755-y</ArticleId><ArticleId IdType="pubmed">24322391</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampugnani M.G., Zanetti A., Breviario F., Balconi G., Orsenigo F., Corada M., Spagnuolo R., Betson M., Braga V., Dejana E. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol. Biol. Cell. 2002;13:1175&#x2013;1189. doi: 10.1091/mbc.01-07-0368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.01-07-0368</ArticleId><ArticleId IdType="pmc">PMC102260</ArticleId><ArticleId IdType="pubmed">11950930</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopperud R.K., Rygh C.B., Karlsen T.V., Krakstad C., Kleppe R., Hoivik E.A., Bakke M., Tenstad O., Selheim F., Lid&#xe9;n, et al. Increased microvascular permeability in mice lacking Epac1 (Rapgef3) Acta Physiol. 2017;219:441&#x2013;452. doi: 10.1111/apha.12697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12697</ArticleId><ArticleId IdType="pmc">PMC5073050</ArticleId><ArticleId IdType="pubmed">27096875</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullere X., Shaw S.K., Andersson L., Hirahashi J., Luscinskas F.W., Mayadas T.N. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood. 2005;105:1950&#x2013;1955. doi: 10.1182/blood-2004-05-1987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-05-1987</ArticleId><ArticleId IdType="pubmed">15374886</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel C.C., Curry F.E. Microvascular permeability. Physiol. Rev. 1999;79:703&#x2013;761. doi: 10.1152/physrev.1999.79.3.703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1999.79.3.703</ArticleId><ArticleId IdType="pubmed">10390517</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry F.R.E., Adamson R.H. Tonic regulation of vascular permeability. Acta Physiol. 2013;207:628&#x2013;649. doi: 10.1111/apha.12076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12076</ArticleId><ArticleId IdType="pmc">PMC4054936</ArticleId><ArticleId IdType="pubmed">23374222</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel N., Baumer Y., Drenckhahn D., Waschke J. Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro. Crit. Care Med. 2009;37:1735&#x2013;1743. doi: 10.1097/CCM.0b013e31819deb6a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31819deb6a</ArticleId><ArticleId IdType="pubmed">19325485</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel N., Waschke J. Impaired cAMP and Rac 1 signaling contribute to TNF-alpha-induced endothelial barrier breakdown in microvascular endothelium. Microcirculation. 2009;16:521&#x2013;533. doi: 10.1080/10739680902967427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10739680902967427</ArticleId><ArticleId IdType="pubmed">19504398</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumer Y., Spindler V., Werthmann R.C., B&#xfc;nemann M., Waschke J. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J. Cell. Physiol. 2009;220:716&#x2013;726. doi: 10.1002/jcp.21819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.21819</ArticleId><ArticleId IdType="pubmed">19472214</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam M., Tanislav C., Troidl C., Schulz R., Hamm C., G&#xfc;nd&#xfc;z D. cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation. Physiol. Rep. 2014;2:e12175. doi: 10.14814/phy2.12175.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12175</ArticleId><ArticleId IdType="pmc">PMC4254100</ArticleId><ArticleId IdType="pubmed">25344477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E., Orsenigo F. Endothelial adherens junctions at a glance. J. Cell Sci. 2013;126 Pt. 12:2545&#x2013;2549. doi: 10.1242/jcs.124529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.124529</ArticleId><ArticleId IdType="pubmed">23781019</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ppers V., Vockel M., Nottebaum A.F., Vestweber D. Phosphatases and kinases as regulators of the endothelial barrier function. Cell Tissue Res. 2014;355:577&#x2013;586. doi: 10.1007/s00441-014-1812-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-014-1812-1</ArticleId><ArticleId IdType="pubmed">24566520</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler V., Schlegel N., Waschke J. Role of GTPases in control of microvascular permeability. Cardiovasc. Res. 2010;87:243&#x2013;253. doi: 10.1093/cvr/cvq086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvq086</ArticleId><ArticleId IdType="pubmed">20299335</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojciak-Stothard B., Ridley A.J. Rho GTPases and the regulation of endothelial permeability. Vasc. Pharmacol. 2002;39:187&#x2013;199. doi: 10.1016/S1537-1891(03)00008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1537-1891(03)00008-9</ArticleId><ArticleId IdType="pubmed">12747959</ArticleId></ArticleIdList></Reference><Reference><Citation>Flemming S., Burkard N., Renschler M., Vielmuth F., Meir M., Schick M.A., Wunder C., Germer C.T., Spindler V., Waschke J., et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc. Res. 2015;107:32&#x2013;44. doi: 10.1093/cvr/cvv144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvv144</ArticleId><ArticleId IdType="pubmed">25975259</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsenigo F., Giampietro C., Ferrari A., Corada M., Galaup A., Sigismund S., Ristagno G., Maddaluno L., Koh G.Y., Franco D., et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat. Commun. 2012;3:1208. doi: 10.1038/ncomms2199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2199</ArticleId><ArticleId IdType="pmc">PMC3514492</ArticleId><ArticleId IdType="pubmed">23169049</ArticleId></ArticleIdList></Reference><Reference><Citation>Garatti L., Wu M.A., Ammirati E., Sacco A. Systemic leak capillary syndrome with myocardial involvement and cardiogenic shock: A case report. Eur. Heart J.-Case Reports. 2022;6:ytac262. doi: 10.1093/ehjcr/ytac262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytac262</ArticleId><ArticleId IdType="pmc">PMC9258032</ArticleId><ArticleId IdType="pubmed">35799677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yacoub S., Wertheim H., Simmons C.P., Screaton G., Wills B. Cardiovascular manifestations of the emerging dengue pandemic. Nat. Rev. Cardiol. 2014;11:335&#x2013;345. doi: 10.1038/nrcardio.2014.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2014.40</ArticleId><ArticleId IdType="pubmed">24710495</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering S.B., Gomes de Sousa F.T., Tjang L.V., Pahmeier F., Zhu C., Ruan R., Blanc S.F., Patel T.S., Worthington C.M., Glasner D.R., et al. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-&#x3b2; signaling. Nat. Commun. 2022;13:7630. doi: 10.1038/s41467-022-34910-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34910-5</ArticleId><ArticleId IdType="pmc">PMC9734751</ArticleId><ArticleId IdType="pubmed">36494335</ArticleId></ArticleIdList></Reference><Reference><Citation>Dongaonkar R.M., Stewart R.H., Quick C.M., Uray K.L., Cox C.S., Laine G.A. Award article: Microcirculatory Society Award for Excellence in Lymphatic Research: Time course of myocardial interstitial edema resolution and associated left ventricular dysfunction. Microcirculation. 2012;19:714&#x2013;722. doi: 10.1111/j.1549-8719.2012.00204.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1549-8719.2012.00204.x</ArticleId><ArticleId IdType="pmc">PMC3502725</ArticleId><ArticleId IdType="pubmed">22708850</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt J.W., Schertel E.R., Schaefer S.L., Esham K.E., McClure D.E., Heck C.F., Myerowitz P.D. Acute transient coronary sinus hypertension impairs left ventricular function and induces myocardial edema. Am. J. Physiol. 1996;271:H834&#x2013;H841. doi: 10.1152/ajpheart.1996.271.3.H834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1996.271.3.H834</ArticleId><ArticleId IdType="pubmed">8853315</ArticleId></ArticleIdList></Reference><Reference><Citation>Dongaonkar R.M., Stewart R.H., Geissler H.J., Laine G.A. Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. Cardiovasc. Res. 2010;87:331&#x2013;339. doi: 10.1093/cvr/cvq145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvq145</ArticleId><ArticleId IdType="pmc">PMC2895547</ArticleId><ArticleId IdType="pubmed">20472566</ArticleId></ArticleIdList></Reference><Reference><Citation>Taherzadeh M., Das A.K., Warren J.B. Nifedipine increases microvascular permeability via a direct local effect on postcapillary venules. Am. J. Physiol. 1998;275:H1388&#x2013;H1394. doi: 10.1152/ajpheart.1998.275.4.H1388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1998.275.4.H1388</ArticleId><ArticleId IdType="pubmed">9746489</ArticleId></ArticleIdList></Reference><Reference><Citation>Monmeneu J.V., Bod&#xed; V., Sanchis J., L&#xf3;pez-Lereu M.P., Mainar L., N&#xfa;&#xf1;ez J., Chaustre F., Rumiz E., Chorro F.J., Ll&#xe1;cer &#xc1;. Cardiac magnetic resonance evaluation of edema after ST-elevation acute myocardial infarction. Rev. Esp. Cardiol. 2009;62:858&#x2013;866. doi: 10.1016/S0300-8932(09)72068-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-8932(09)72068-8</ArticleId><ArticleId IdType="pubmed">19706241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehrmann A., Treutlein M., Rudolph T., Rudolph V., Weiss K., Giese D., Bunck A.C., Maintz D., Bae&#xdf;ler B. Myocardial T1 and T2 mapping in severe aortic stenosis: Potential novel insights into the pathophysiology of myocardial remodelling. Eur. J. Radiol. 2018;107:76&#x2013;83. doi: 10.1016/j.ejrad.2018.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2018.08.016</ArticleId><ArticleId IdType="pubmed">30292277</ArticleId></ArticleIdList></Reference><Reference><Citation>Alabed S., Saunders L., Garg P., Shahin Y., Alandejani F., Rolf A., Puntmann V.O., Nagel E., Wild J.M., Kiely D.G., et al. Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis. Magn. Reson. Imaging. 2021;79:66&#x2013;75. doi: 10.1016/j.mri.2021.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2021.03.011</ArticleId><ArticleId IdType="pubmed">33745961</ArticleId></ArticleIdList></Reference><Reference><Citation>Spieker M., Haberkorn S., Gastl M., Behm P., Katsianos S., Horn P., Jacoby C., Schnackenburg B., Reinecke P., Kelm M., et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J. Cardiovasc. Magn. Reson. 2017;19:38. doi: 10.1186/s12968-017-0350-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-017-0350-x</ArticleId><ArticleId IdType="pmc">PMC5370450</ArticleId><ArticleId IdType="pubmed">28351402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xe4;ni C., Eichhorn C., Bi&#xe8;re L., Murthy V.L., Agarwal V., Kaneko K., Cuddy S., Aghayev A., Steigner M., Blankstein R., et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients with Suspected Myocarditis. J. Am. Coll. Cardiol. 2017;70:1964. doi: 10.1016/j.jacc.2017.08.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.08.050</ArticleId><ArticleId IdType="pmc">PMC6506846</ArticleId><ArticleId IdType="pubmed">29025553</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson L.W., Tillisch J.H. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation. 1986;74:1303&#x2013;1308. doi: 10.1161/01.CIR.74.6.1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.74.6.1303</ArticleId><ArticleId IdType="pubmed">3779915</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine G.A., Allen S.J., Katz J., Gabel J.C., Drake R.E. Effect of systemic venous pressure elevation on lymph flow and lung edema formation. J. Appl. Physiol. 1986;61:1634&#x2013;1638. doi: 10.1152/jappl.1986.61.5.1634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1986.61.5.1634</ArticleId><ArticleId IdType="pubmed">3781976</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson A.D., Ramanathan K.B., McGee J.E., Newman K.P., Weber K.T. Oxidative stress and cardiomyocyte necrosis with elevated serum troponins: Pathophysiologic mechanisms. Am. J. Med. Sci. 2011;342:129&#x2013;134. doi: 10.1097/MAJ.0b013e3182231ee3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0b013e3182231ee3</ArticleId><ArticleId IdType="pubmed">21747281</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo P.C., Onat D., Harxhi A., Demmer R.T., Hayashi Y., Jelic S., Lejemtel T.H., Bucciarelli L., Kebschull M., Papapanou P., et al. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur. Heart J. 2014;35:448&#x2013;454. doi: 10.1093/eurheartj/eht456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht456</ArticleId><ArticleId IdType="pmc">PMC3924182</ArticleId><ArticleId IdType="pubmed">24265434</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P. The Heart in COVID-19: Primary Target or Secondary Bystander? JACC Basic Transl. Sci. 2020;5:537&#x2013;542. doi: 10.1016/j.jacbts.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7151324</ArticleId><ArticleId IdType="pubmed">32292847</ArticleId></ArticleIdList></Reference><Reference><Citation>Folco E.J., Mawson T.L., Vromman A., Bernardes-Souza B., Franck G., Persson O., Nakamura M., Newton G., Luscinskas F.W., Libby P. Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1&#x3b1; and Cathepsin G. Arter. Thromb. Vasc. Biol. 2018;38:1901&#x2013;1912. doi: 10.1161/ATVBAHA.118.311150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.118.311150</ArticleId><ArticleId IdType="pmc">PMC6202190</ArticleId><ArticleId IdType="pubmed">29976772</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus A.J., Broekman M.J., Drosopoulos J.H.F., Islam N., Alyonycheva T.N., Safier L.B., Hajjar K.A., Posnett D.N., Schoenborn M.A., Schooley K.A., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J. Clin. Investig. 1997;99:1351&#x2013;1360. doi: 10.1172/JCI119294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI119294</ArticleId><ArticleId IdType="pmc">PMC507951</ArticleId><ArticleId IdType="pubmed">9077545</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy C., Tabiasco J., Caillon A., Delneste Y., Merot J., Favre J., Guihot A.L., Martin L., Nascimento D.C., Ryffel B., et al. Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension. Purinergic Signal. 2018;14:73&#x2013;82. doi: 10.1007/s11302-017-9597-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-017-9597-9</ArticleId><ArticleId IdType="pmc">PMC5842157</ArticleId><ArticleId IdType="pubmed">29236227</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson S.C., Kaczmarek E., Siegel J.B., Candinas D., Koziak K., Millan M., Hancock W.W., Bach F.H. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 1997;185:153&#x2013;163. doi: 10.1084/jem.185.1.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.185.1.153</ArticleId><ArticleId IdType="pmc">PMC2196106</ArticleId><ArticleId IdType="pubmed">8996251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L.H., Kuo M.L., Chen C.A., Chou C.H., Lai K.B., Lee C.N., Hsieh C.Y. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene. 2003;22:1517&#x2013;1527. doi: 10.1038/sj.onc.1206226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1206226</ArticleId><ArticleId IdType="pubmed">12629515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii K., Sasaki T., Iguchi K., Kajiwara S., Kato M., Kanda H., Hirokawa Y., Arima K., Mizokami A., Sugimura Y. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation. Prostate. 2018;78:849&#x2013;856. doi: 10.1002/pros.23643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pros.23643</ArticleId><ArticleId IdType="pubmed">29707793</ArticleId></ArticleIdList></Reference><Reference><Citation>Soga N., Namba N., McAllister S., Cornelius L., Teitelbaum S.L., Dowdy S.F., Kawamura J., Hruska K.A. Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp. Cell Res. 2001;269:73&#x2013;87. doi: 10.1006/excr.2001.5295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.2001.5295</ArticleId><ArticleId IdType="pubmed">11525641</ArticleId></ArticleIdList></Reference><Reference><Citation>Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 2007;7:803&#x2013;815. doi: 10.1038/nri2171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2171</ArticleId><ArticleId IdType="pubmed">17893694</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse R., Fleming I. Vascular endothelium and blood flow. Handb. Exp. Pharmacol. 2006;176:43&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">16999224</ArticleId></ArticleIdList></Reference><Reference><Citation>Moncada S., Higgs E.A. Nitric oxide and the vascular endothelium. Handb. Exp. Pharmacol. 2006;176:213&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">16999221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcdonald D.M., Thurston G., Baluk P. Endothelial Gaps as Sites for Plasma Leakage in Inflammation. Microcirculation. 1999;6:7&#x2013;22. doi: 10.1080/713773924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/713773924</ArticleId><ArticleId IdType="pubmed">10100186</ArticleId></ArticleIdList></Reference><Reference><Citation>Siao C.J., Lorentz C.U., Kermani P., Marinic T., Carter J., McGrath K., Padow V.A., Mark W., Falcone D.J., Leona C.G., et al. ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation. J. Exp. Med. 2012;209:2291&#x2013;2305. doi: 10.1084/jem.20111749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111749</ArticleId><ArticleId IdType="pmc">PMC3501352</ArticleId><ArticleId IdType="pubmed">23091165</ArticleId></ArticleIdList></Reference><Reference><Citation>Armulik A., Genov&#xe9; G., Betsholtz C. Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises. Dev. Cell. 2011;21:193&#x2013;215. doi: 10.1016/j.devcel.2011.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2011.07.001</ArticleId><ArticleId IdType="pubmed">21839917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Cao C., Chen Z., Bankaitis V., Tzima E., Sheibani N., Burridge K. Pericytes Regulate Vascular Basement Membrane Remodeling and Govern Neutrophil Extravasation during Inflammation. PLoS ONE. 2012;7:e45499. doi: 10.1371/journal.pone.0045499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045499</ArticleId><ArticleId IdType="pmc">PMC3448630</ArticleId><ArticleId IdType="pubmed">23029055</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Flores L., Guti&#xe9;rrez R., Madrid J.F., Varela H., Valladares F., Acosta E., Mart&#xed;n-Vasallo P., D&#xed;az-Flores J. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 2009;24:909&#x2013;969. doi: 10.14670/HH-24.909.</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/HH-24.909</ArticleId><ArticleId IdType="pubmed">19475537</ArticleId></ArticleIdList></Reference><Reference><Citation>Peppiatt C.M., Howarth C., Mobbs P., Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature. 2006;443:700&#x2013;704. doi: 10.1038/nature05193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05193</ArticleId><ArticleId IdType="pmc">PMC1761848</ArticleId><ArticleId IdType="pubmed">17036005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li X., Chen M., Feng Y., Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 2020;116:1097&#x2013;1100. doi: 10.1093/cvr/cvaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsson C., H&#xe4;llgren R., Elvin A., Gerdin B., Tufveson G. Hyaluronidase ameliorates rejection-induced edema. Transpl. Int. 1999;12:235&#x2013;243. doi: 10.1111/j.1432-2277.1999.tb01207.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-2277.1999.tb01207.x</ArticleId><ArticleId IdType="pubmed">10460867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D.G. Leucocyte Trafficking via the Lymphatic Vasculature- Mechanisms and Consequences. Front. Immunol. 2019;10:471. doi: 10.3389/fimmu.2019.00471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00471</ArticleId><ArticleId IdType="pmc">PMC6426755</ArticleId><ArticleId IdType="pubmed">30923528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwager S., Detmar M. Inflammation and Lymphatic Function. Front. Immunol. 2019;10:308. doi: 10.3389/fimmu.2019.00308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00308</ArticleId><ArticleId IdType="pmc">PMC6399417</ArticleId><ArticleId IdType="pubmed">30863410</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister F., Feng Y., Vom Hagen F., Hoffmann S., Molema G., Hillebrands J.L., Shani M., Deutsch U., Hammes H.P. Pericyte MigrationA Novel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy. Diabetes. 2008;57:2495&#x2013;2502. doi: 10.2337/db08-0325.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db08-0325</ArticleId><ArticleId IdType="pmc">PMC2518502</ArticleId><ArticleId IdType="pubmed">18559662</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry F.R.E. Atrial natriuretic peptide: An essential physiological regulator of transvascular fluid, protein transport, and plasma volume. J. Clin. Investig. 2005;115:1458&#x2013;1461. doi: 10.1172/JCI25417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI25417</ArticleId><ArticleId IdType="pmc">PMC1137012</ArticleId><ArticleId IdType="pubmed">15931381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D., Bruegger D., Potzel J., Jacob M., Brettner F., Vogeser M., Conzen P., Becker B.F., Rehm M. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit. Care. 2014;18:538. doi: 10.1186/s13054-014-0538-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0538-5</ArticleId><ArticleId IdType="pmc">PMC4201669</ArticleId><ArticleId IdType="pubmed">25497357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira V.M., Schulz-Menger J., Holmvang G., Kramer C.M., Carbone I., Sechtem U., Kindermann I., Gutberlet M., Cooper L.T., Liu P., et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J. Am. Coll. Cardiol. 2018;72:3158&#x2013;3176. doi: 10.1016/j.jacc.2018.09.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Iles L.M., Ellims A.H., Llewellyn H., Hare J.L., Kaye D.M., McLean C.A., Taylor A.J. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur. Heart J. Cardiovasc. Imaging. 2015;16:14&#x2013;22. doi: 10.1093/ehjci/jeu182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeu182</ArticleId><ArticleId IdType="pubmed">25354866</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano A., Benedetti G., Faletti R., Rancoita P.M.V., Gatti M., Peretto G., Sala S., Boccia E., Francone M., Galea N., et al. Early T1 Myocardial MRI Mapping: Value in Detecting Myocardial Hyperemia in Acute Myocarditis. Radiology. 2020;295:316&#x2013;325. doi: 10.1148/radiol.2020191623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020191623</ArticleId><ArticleId IdType="pubmed">32154772</ArticleId></ArticleIdList></Reference><Reference><Citation>Beijnink C.W.H., van der Hoeven N.W., Konijnenberg L.S.F., Kim R.J., Bekkers S.C.A.M., Kloner R.A., Everaars H., El Messaoudi S., van Rossum A.C., van Royen N., et al. Cardiac MRI to Visualize Myocardial Damage after ST-Segment Elevation Myocardial Infarction: A Review of Its Histologic Validation. Radiology. 2021;301:4&#x2013;18. doi: 10.1148/radiol.2021204265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204265</ArticleId><ArticleId IdType="pubmed">34427461</ArticleId></ArticleIdList></Reference><Reference><Citation>Masci P.G., Pavon A.G., Muller O., Iglesias J.F., Vincenti G., Monney P., Harbaoui B., Eeckhout E., Schwitter J. Relationship between CMR-derived parameters of ischemia/reperfusion injury and the timing of CMR after reperfused ST-segment elevation myocardial infarction. J. Cardiovasc. Magn. Reson. 2018;20:50. doi: 10.1186/s12968-018-0474-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-018-0474-7</ArticleId><ArticleId IdType="pmc">PMC6055335</ArticleId><ArticleId IdType="pubmed">30037343</ArticleId></ArticleIdList></Reference><Reference><Citation>Templin C., Manka R., Cammann V.L., Szawan K.A., Gotschy A., Karolyi M., Winnik S., Moch H., Meyer P., Moreo A., et al. Takotsubo Syndrome in Coronavirus Disease 2019. Am. J. Cardiol. 2021;138:118. doi: 10.1016/j.amjcard.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7546657</ArticleId><ArticleId IdType="pubmed">33045199</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao C.W., Strom J.B., Chang J.D., Manning W.J. COVID-19 Associated Stress (Takotsubo) Cardiomyopathy. Circ. Cardiovasc. Imaging. 2020;13:e011222. doi: 10.1161/CIRCIMAGING.120.011222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.120.011222</ArticleId><ArticleId IdType="pmc">PMC7398589</ArticleId><ArticleId IdType="pubmed">32673494</ArticleId></ArticleIdList></Reference><Reference><Citation>Pl&#xe1;cido R., Cunha Lopes B., Almeida A.G., Rochitte C.E. The role of cardiovascular magnetic resonance in takotsubo syndrome. J. Cardiovasc. Magn. Reson. 2016;18:68. doi: 10.1186/s12968-016-0279-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-016-0279-5</ArticleId><ArticleId IdType="pmc">PMC5059937</ArticleId><ArticleId IdType="pubmed">27729054</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutberlet M., Spors B., Thoma T., Bertram H., Denecke T., Felix R., Noutsias M., Schultheiss H.-P., K&#xfc;hl U. Suspected chronic myocarditis at cardiac MR: Diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008;246:401&#x2013;409. doi: 10.1148/radiol.2461062179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2461062179</ArticleId><ArticleId IdType="pubmed">18180335</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Liu B.T., Yuan W.F., Zhao C.X. Frontiers of COVID-19-related myocarditis as assessed by cardiovascular magnetic resonance. World J. Clin. Cases. 2022;10:6784. doi: 10.12998/wjcc.v10.i20.6784.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i20.6784</ArticleId><ArticleId IdType="pmc">PMC9297411</ArticleId><ArticleId IdType="pubmed">36051125</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., B&#xf6;hm M., Burri H., Butler J., Celutkiene J., Chioncel O., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599&#x2013;3726. doi: 10.1093/eurheartj/ehab368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio A.L.P., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B., Fu M., Heli&#xf6; T., Heymans S., Jahns R., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013;34:2636&#x2013;2648. doi: 10.1093/eurheartj/eht210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Piechota-Pola&#x144;czyk A., Andreas M., Kopp C.W. Cardiovascular Disease Management in the Context of Global Crisis. Int. J. Environ. Res. Public Health. 2022;20:689. doi: 10.3390/ijerph20010689.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010689</ArticleId><ArticleId IdType="pmc">PMC9819164</ArticleId><ArticleId IdType="pubmed">36613012</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B., Asatryan B., Hanff T.C., Chatha S.R., Khanji M.Y., Ricci F., Muser D., Ferrari V.A., Nazarian S., Santangeli P., et al. The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury. JACC Basic Transl. Sci. 2022;7:294&#x2013;308. doi: 10.1016/j.jacbts.2021.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8828362</ArticleId><ArticleId IdType="pubmed">35165665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang Z. Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China. Eur. J. Med. Chem. 2023;257:115503. doi: 10.1016/j.ejmech.2023.115503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2023.115503</ArticleId><ArticleId IdType="pmc">PMC10193775</ArticleId><ArticleId IdType="pubmed">37229831</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.L., Li Y.H., Wang L.L., Liu H.Q., Lu S.Y., Liu Y., Li K., Liu B., Li S.Y., Shao F.M., et al. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal Transduct. Target. Ther. 2021;6:414. doi: 10.1038/s41392-021-00835-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00835-6</ArticleId><ArticleId IdType="pmc">PMC8646019</ArticleId><ArticleId IdType="pubmed">34873151</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Yin W., Zhang Y., Shang W., Wang Z., Luan X., Tian G., Aisa H.A., Xu Y., Xiao G., et al. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2. Cell Res. 2021;31:1212&#x2013;1214. doi: 10.1038/s41422-021-00570-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00570-1</ArticleId><ArticleId IdType="pmc">PMC8477624</ArticleId><ArticleId IdType="pubmed">34584244</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema H.A., Rehman A.U., Elrashedy A.A., Mohsin A., Shahid A., Ehsan M., Ayyan M., Ismail H., Almas T. Antiandrogens for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials. J. Med. Virol. 2023;95:e28740. doi: 10.1002/jmv.28740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28740</ArticleId><ArticleId IdType="pubmed">37185842</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang W., Dai W., Yao C., Xu L., Tao X., Su H., Li J., Xie X., Xu Y., Hu M., et al. In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2. Antiviral Res. 2022;208:105450. doi: 10.1016/j.antiviral.2022.105450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105450</ArticleId><ArticleId IdType="pmc">PMC9617675</ArticleId><ArticleId IdType="pubmed">36354082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou N., Shuai L., Zhang L., Xie X., Tang K., Zhu Y., Yu Y., Zhang W., Tan Q., Zhong G., et al. Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro. ACS Cent. Sci. 2022;9:217&#x2013;227. doi: 10.1021/acscentsci.2c01359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.2c01359</ArticleId><ArticleId IdType="pmc">PMC9885526</ArticleId><ArticleId IdType="pubmed">36844503</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih P.C., Mao Y.W., Hu J.W., Hsieh H.Y., Shih T.M., Lu L.P., Chang W.H., Huang C.H., Lin C.H., Lin C.H., et al. Development of Ultrapure and Potent Tannic Acids asa Pan-coronal Antiviral Therapeutic. ACS Pharmacol. Transl. Sci. 2022;5:400. doi: 10.1021/acsptsci.1c00264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.1c00264</ArticleId><ArticleId IdType="pmc">PMC9128009</ArticleId><ArticleId IdType="pubmed">37582235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi H., Watashi K., Saso W., Shionoya K., Iwanami S., Hirokawa T., Shirai T., Kanaya S., Ito Y., Kim K.S., et al. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021;24:102367. doi: 10.1016/j.isci.2021.102367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102367</ArticleId><ArticleId IdType="pmc">PMC7997640</ArticleId><ArticleId IdType="pubmed">33817567</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.P., Blet A., Smyth D., Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020;142:68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad K., AlOmar S.Y., Almuqri E.A., Rudayni H.A., Kumar V. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L. PLoS ONE. 2021;16:e0256141. doi: 10.1371/journal.pone.0256141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256141</ArticleId><ArticleId IdType="pmc">PMC8372896</ArticleId><ArticleId IdType="pubmed">34407143</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R., Yin W., Napoleon M.A., Suder E.L., Berrigan J., Zhao Q., Olejnik J., Chandler K.B., Xia C., Feldman J., et al. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Central Sci. 2021;7:1156&#x2013;1165. doi: 10.1021/acscentsci.0c01537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01537</ArticleId><ArticleId IdType="pmc">PMC8265543</ArticleId><ArticleId IdType="pubmed">34341769</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Jambrina M., Eder J., Kaptein T.M., van Hamme J.L., Helgers L.C., Vlaming K.E., Brouwer P.J.M., van Nuenen A.C., Spaargaren M., de Bree G.J., et al. Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans. EMBO J. 2021;40:e106765. doi: 10.15252/embj.2020106765.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106765</ArticleId><ArticleId IdType="pmc">PMC8521309</ArticleId><ArticleId IdType="pubmed">34510494</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Wang Y., Wang H., Gao Z., Wang Y., Fang M., Shi S., Zhang P., Wang H., Su Y., et al. Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients with Coronavirus Disease 2019. Front. Microbiol. 2022;13:948770. doi: 10.3389/fmicb.2022.948770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.948770</ArticleId><ArticleId IdType="pmc">PMC9271922</ArticleId><ArticleId IdType="pubmed">35832809</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone C., Faraco G., Park L., Cao X., Davisson R.L., Iadecola C. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am. J. Physiol.-Heart Circ. Physiol. 2011;300:397&#x2013;407. doi: 10.1152/ajpheart.00679.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00679.2010</ArticleId><ArticleId IdType="pmc">PMC3023263</ArticleId><ArticleId IdType="pubmed">20971763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura H., Kobayashi M., Li Q., Yamanishi S., Katsumura K., Minami M., Wu D.M., Puro D.G. Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina. J. Physiol. 2004;561:671&#x2013;683. doi: 10.1113/jphysiol.2004.073098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2004.073098</ArticleId><ArticleId IdType="pmc">PMC1665385</ArticleId><ArticleId IdType="pubmed">15486015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilton R.G., Kilo C., Williamson J.R., Murch D.W. Differences in pericyte contractile function in rat cardiac and skeletal muscle microvasculatures. Microvasc. Res. 1979;18:336&#x2013;352. doi: 10.1016/0026-2862(79)90042-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-2862(79)90042-6</ArticleId><ArticleId IdType="pubmed">537511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram S., Heurich A., Lavender H., Gierer S., Danisch S., Perin P., Lucas J.M., Nelson P.S., P&#xf6;hlmann S., Soilleux E.J. Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts. PLoS ONE. 2012;7:e35876. doi: 10.1371/journal.pone.0035876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035876</ArticleId><ArticleId IdType="pmc">PMC3340400</ArticleId><ArticleId IdType="pubmed">22558251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto A., Kawakami R., Kawai K., Gianatti A., Pellegrini D., Kutys R., Guo L., Mori M., Cornelissen A., Sato Y., et al. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart. Arter. Thromb. Vasc. Biol. 2021;41:542&#x2013;544. doi: 10.1161/ATVBAHA.120.315229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315229</ArticleId><ArticleId IdType="pubmed">33086866</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkou E., Barnasas G., Vougas K., Trougakos I.P. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol. 2020;36:101615. doi: 10.1016/j.redox.2020.101615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101615</ArticleId><ArticleId IdType="pmc">PMC7311357</ArticleId><ArticleId IdType="pubmed">32863223</ArticleId></ArticleIdList></Reference><Reference><Citation>Batah S.S., Fabro A.T. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Respir. Med. 2021;176:106239. doi: 10.1016/j.rmed.2020.106239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106239</ArticleId><ArticleId IdType="pmc">PMC7674971</ArticleId><ArticleId IdType="pubmed">33246294</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L., Sonzogni A., Nasr A., Rossi R.S., Pellegrinelli A., Zerbi P., Rech R., Colombo R., Antinori S., Corbellino M., et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-centre descriptive study. Lancet Infect. Dis. 2020;20:1135&#x2013;1140. doi: 10.1016/S1473-3099(20)30434-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30434-5</ArticleId><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y., Katano H., Nakajima N., Sato Y., Suzuki T., Sekizuka T., Kuroda M., Izutani Y., Morimoto S., Maruyama J., et al. SARS-CoV-2 is localized in cardiomyocytes: A postmortem biopsy case. Int. J. Infect. Dis. 2021;111:43. doi: 10.1016/j.ijid.2021.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.08.015</ArticleId><ArticleId IdType="pmc">PMC8351278</ArticleId><ArticleId IdType="pubmed">34384897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.H., Lui R.N.S., Sung J.J.Y. Covid-19 and the digestive system. J. Gastroenterol. Hepatol. 2020;35:744&#x2013;748. doi: 10.1111/jgh.15047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15047</ArticleId><ArticleId IdType="pubmed">32215956</ArticleId></ArticleIdList></Reference><Reference><Citation>Trougakos I.P., Stamatelopoulos K., Terpos E., Tsitsilonis O.E., Aivalioti E., Paraskevis D., Kastritis E., Pavlakis G.N., Dimopoulos M.A. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J. Biomed. Sci. 2021;28:9. doi: 10.1186/s12929-020-00703-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-00703-5</ArticleId><ArticleId IdType="pmc">PMC7801873</ArticleId><ArticleId IdType="pubmed">33435929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.H., Nijst P., Kiefer K., Tang W.H.W. Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications. Curr. Heart Fail. Rep. 2017;14:117&#x2013;126. doi: 10.1007/s11897-017-0320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-017-0320-5</ArticleId><ArticleId IdType="pmc">PMC5386320</ArticleId><ArticleId IdType="pubmed">28233259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., H&#xfc;lsmann M., Sch&#xf6;rgenhofer C., Lang I.M., Wurm R., Gremmel T., Koppensteiner R., Steinlechner B., Schwameis M., Jilma B. Sublingual functional capillary rarefaction in chronic heart failure. Eur. J. Clin. Investig. 2018;48:e12869. doi: 10.1111/eci.12869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12869</ArticleId><ArticleId IdType="pubmed">29178250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Steinlechner B., Zimpfer D., Schl&#xf6;glhofer T., Schima H., H&#xfc;lsmann M., Lang I.M., Gremmel T., Koppensteiner R., Zehetmayer S., et al. Functional capillary impairment in patients with ventricular assist devices. Sci. Rep. 2019;9:5909. doi: 10.1038/s41598-019-42334-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42334-3</ArticleId><ArticleId IdType="pmc">PMC6459831</ArticleId><ArticleId IdType="pubmed">30976042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Sch&#xf6;rgenhofer C., Rieder T., Ertl S., Pultar J., Serles W., Sycha T., Mayer F., Koppensteiner R., Gremmel T., et al. Microvascular rarefaction in patients with cerebrovascular events. Microvasc. Res. 2022;140:104300. doi: 10.1016/j.mvr.2021.104300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104300</ArticleId><ArticleId IdType="pubmed">34953822</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Xiao W., Liang X., Shi L., Zhang P., Wang Y., Wang Y., Yang H. A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity. BMC Public Health. 2021;21:1533. doi: 10.1186/s12889-021-11051-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11051-w</ArticleId><ArticleId IdType="pmc">PMC8355578</ArticleId><ArticleId IdType="pubmed">34380456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerotziafas G.T., Catalano M., Colgan M.P., Pecsvarady Z., Wautrecht J.C., Fazeli B., Olinic D.M., Farkas K., Elalamy I., Falanga A., et al. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb. Haemost. 2020;120:1597&#x2013;1628. doi: 10.1055/S-0040-1715798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/S-0040-1715798</ArticleId><ArticleId IdType="pmc">PMC7869052</ArticleId><ArticleId IdType="pubmed">32920811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C., Reis T., Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir. Med. 2020;8:738&#x2013;742. doi: 10.1016/S2213-2600(20)30229-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30229-0</ArticleId><ArticleId IdType="pmc">PMC7255232</ArticleId><ArticleId IdType="pubmed">32416769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah W., Saeed R., Sarwar U., Patel R., Fischman D.L. COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC Case Rep. 2020;2:1379&#x2013;1382. doi: 10.1016/j.jaccas.2020.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7164919</ArticleId><ArticleId IdType="pubmed">32313884</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Liu L., Zhang D., Xu J., Dai H., Tang N., Su X., Cao B. SARS-CoV-2 and viral sepsis: Observations and hypotheses. Lancet. 2020;395:1517&#x2013;1520. doi: 10.1016/S0140-6736(20)30920-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30920-X</ArticleId><ArticleId IdType="pmc">PMC7164875</ArticleId><ArticleId IdType="pubmed">32311318</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., Cooper Jr L.T., Chahal C.A.A. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17:1463&#x2013;1471. doi: 10.1016/j.hrthm.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Antzelevitch C., Burashnikov A. Overview of Basic Mechanisms of Cardiac Arrhythmia. Card. Electrophysiol. Clin. 2011;3:23&#x2013;45. doi: 10.1016/j.ccep.2010.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2010.10.012</ArticleId><ArticleId IdType="pmc">PMC3164530</ArticleId><ArticleId IdType="pubmed">21892379</ArticleId></ArticleIdList></Reference><Reference><Citation>Avolio E., Madeddu P. Discovering cardiac pericyte biology: From physiopathological mechanisms to potential therapeutic applications in ischemic heart disease. Vasc. Pharmacol. 2016;86:53&#x2013;63. doi: 10.1016/j.vph.2016.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2016.05.009</ArticleId><ArticleId IdType="pubmed">27268036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M., Foldes G. It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease. Front. Cardiovasc. Med. 2018;5:413767. doi: 10.3389/fcvm.2018.00154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2018.00154</ArticleId><ArticleId IdType="pmc">PMC6218412</ArticleId><ArticleId IdType="pubmed">30425990</ArticleId></ArticleIdList></Reference><Reference><Citation>Bontekoe J., Lee J., Bansal V., Syed M., Hoppensteadt D., Maia P., Walborn A., Liles J., Brailovsky E., Fareed J. Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial Fibrillation. Clin. Appl. Thromb. 2018;24:269S&#x2013;276S. doi: 10.1177/1076029618808909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029618808909</ArticleId><ArticleId IdType="pmc">PMC6707900</ArticleId><ArticleId IdType="pubmed">30370780</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Yang Y., Ng C.Y., Zhang Z., Liu T., Li G. Association of Plasma Transforming Growth Factor-&#x3b2;1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis. PLoS ONE. 2016;11:e0155275. doi: 10.1371/journal.pone.0155275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155275</ArticleId><ArticleId IdType="pmc">PMC4865111</ArticleId><ArticleId IdType="pubmed">27171383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nattel S. Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation. JACC Clin. Electrophysiol. 2017;3:425&#x2013;435. doi: 10.1016/j.jacep.2017.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2017.03.002</ArticleId><ArticleId IdType="pubmed">29759598</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.-H., Yeh Y.-H., Lee J.-L., Hsu Y.-J., Kuo C.-T., Chen W.-J. Transforming growth factor-&#x3b2;-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res. Cardiol. 2017;112:58. doi: 10.1007/s00395-017-0647-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-017-0647-9</ArticleId><ArticleId IdType="pubmed">28871329</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao G., Xia D., Cheng Z., Zhang G. miR-132 in atrial fibrillation directly targets connective tissue growth factor. Mol. Med. Rep. 2017;16:4143&#x2013;4150. doi: 10.3892/mmr.2017.7045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7045</ArticleId><ArticleId IdType="pubmed">28731126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee L.L., Chintalgattu V. Pericytes in the Heart. Adv. Exp. Med. Biol. 2019;1122:187&#x2013;210. doi: 10.1007/978-3-030-11093-2_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-11093-2_11</ArticleId><ArticleId IdType="pubmed">30937870</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Yi X., Ma L., Zhou Y. Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway. Exp. Ther. Med. 2013;6:1121&#x2013;1126. doi: 10.3892/etm.2013.1274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2013.1274</ArticleId><ArticleId IdType="pmc">PMC3820834</ArticleId><ArticleId IdType="pubmed">24223632</ArticleId></ArticleIdList></Reference><Reference><Citation>Freestone B., Chong A.Y., Lim H.S., Blann A., Lip G.Y.H. Angiogenic factors in atrial fibrillation: A possible role in thrombogenesis? Ann. Med. 2005;37:365&#x2013;372. doi: 10.1080/07853890510037392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890510037392</ArticleId><ArticleId IdType="pubmed">16179272</ArticleId></ArticleIdList></Reference><Reference><Citation>Doubt T.J., Hogan P.M. Effects of hydrostatic pressure on conduction and excitability in rabbit atria. J. Appl. Physiol. 1978;45:24&#x2013;32. doi: 10.1152/jappl.1978.45.1.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1978.45.1.24</ArticleId><ArticleId IdType="pubmed">670027</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Xue Y.M., Guo H.M., Deng C.Y., Peng D.W., Yang H., Wei W., Liu Y., Liu F.Z., Wang Z.Y., et al. High hydrostatic pressure induces atrial electrical remodeling through upregulation of inflammatory cytokines. Life Sci. 2020;242:117209. doi: 10.1016/j.lfs.2019.117209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.117209</ArticleId><ArticleId IdType="pubmed">31870776</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Deng C.Y., Xue Y.M., Yang H., Wei W., Liu F.Z., Guo H.M., Liu Y., Wang Z.Y., Zhang M.Z., et al. High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation. J. Mol. Cell. Cardiol. 2020;140:10&#x2013;21. doi: 10.1016/j.yjmcc.2020.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.01.012</ArticleId><ArticleId IdType="pubmed">32006532</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger D.N., Rodrigues S.F., Yildirim A., Senchenkova E.Y. Microvascular Responses to Cardiovascular Risk Factors. Microcirculation. 2010;17:192&#x2013;205. doi: 10.1111/j.1549-8719.2009.00015.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1549-8719.2009.00015.x</ArticleId><ArticleId IdType="pmc">PMC3071571</ArticleId><ArticleId IdType="pubmed">20374483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Jilma B., Kopp C.W., Ertl S., Gremmel T., Koppensteiner R. Glycocalyx as Possible Limiting Factor in COVID-19. Front. Immunol. 2021;12:607306. doi: 10.3389/fimmu.2021.607306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.607306</ArticleId><ArticleId IdType="pmc">PMC7937603</ArticleId><ArticleId IdType="pubmed">33692785</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., Guignabert C., Humbert M. Endothelial cell dysfunction: A major player in SARS-CoV-2 infection (COVID-19)? Eur. Respir. J. 2020;56:2001634. doi: 10.1183/13993003.01634-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01634-2020</ArticleId><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K.J., Su I.J., Theron M., Wu Y.C., Lai S.K., Liu C.C., Lei H.Y. An interferon-&#x3b3;-related cytokine storm in SARS patients. J. Med. Virol. 2005;75:185&#x2013;194. doi: 10.1002/jmv.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20255</ArticleId><ArticleId IdType="pmc">PMC7166886</ArticleId><ArticleId IdType="pubmed">15602737</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;olt&#xe9;s L., Mendichi R., Kogan G., Schiller J., Stankovsk&#xe1; M., Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules. 2006;7:659&#x2013;668. doi: 10.1021/bm050867v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bm050867v</ArticleId><ArticleId IdType="pubmed">16529395</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciej-Hulme M.L. New Insights Into Human Hyaluronidase 4/Chondroitin Sulphate Hydrolase. Front. Cell Dev. Biol. 2021;9:767924. doi: 10.3389/fcell.2021.767924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.767924</ArticleId><ArticleId IdType="pmc">PMC8564380</ArticleId><ArticleId IdType="pubmed">34746156</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzner Y., Bar-Ner M., Yahalom J., Ishai-Michaeli R., Fuks Z., Vlodavsky I. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J. Clin. Investig. 1985;76:1306. doi: 10.1172/JCI112104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI112104</ArticleId><ArticleId IdType="pmc">PMC424062</ArticleId><ArticleId IdType="pubmed">2997275</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo K., Takino T., Miyamori H., Kinsen H., Yoshizaki T., Furukawa M., Sato H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 2003;278:40764&#x2013;40770. doi: 10.1074/jbc.M306736200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M306736200</ArticleId><ArticleId IdType="pubmed">12904296</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner D.D. The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. Thromb. Haemost. 1993;70:105&#x2013;110. doi: 10.1055/s-0038-1646169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1646169</ArticleId><ArticleId IdType="pubmed">7694385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R.M., Libby P., Barton M. Linking regulation of nitric oxide to endothelin-1: The Yin and Yang of vascular tone in the atherosclerotic plaque. Atherosclerosis. 2020;292:201&#x2013;203. doi: 10.1016/j.atherosclerosis.2019.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2019.11.001</ArticleId><ArticleId IdType="pmc">PMC7447109</ArticleId><ArticleId IdType="pubmed">31810569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng H., Havervall S., Rosell A., Aguilera K., Parv K., Von Meijenfeldt F.A., Lisman T., Mackman N., Th&#xe5;lin C., Phillipson M. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients with COVID-19. Arter. Thromb. Vasc. Biol. 2021;41:988&#x2013;994. doi: 10.1161/ATVBAHA.120.315267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315267</ArticleId><ArticleId IdType="pmc">PMC7837697</ArticleId><ArticleId IdType="pubmed">33267662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidalgo A. A NET-thrombosis axis in COVID-19. Blood. 2020;136:1118&#x2013;1119. doi: 10.1182/blood.2020007951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007951</ArticleId><ArticleId IdType="pmc">PMC7472712</ArticleId><ArticleId IdType="pubmed">32882018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman T.J., Bhave N.M., Allen L.A., Chung E.H., Spatz E.S., Ammirati E., Baggish A.L., Bozkurt B., Cornwell W.K., Harmon K.G., et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2022;79:1717. doi: 10.1016/J.JACC.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACC.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanneman K., Houbois C., Schoffel A., Gustafson D., Iwanochko R.M., Wintersperger B.J., Chan R., Fish J.E., Howe K.L., Thavendiranathan P. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19. JAMA Cardiol. 2022;7:298&#x2013;308. doi: 10.1001/jamacardio.2021.5505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.5505</ArticleId><ArticleId IdType="pmc">PMC8756363</ArticleId><ArticleId IdType="pubmed">35019953</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada A., Klein J., Ramaswamy A., Brodsky N.N., Jaycox J.R., Sheikha H., Jones K.M., Habet V., Campbell M., Sumida T.S., et al. Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine&#x2013;associated myocarditis. Sci. Immunol. 2023;8:eadh3455. doi: 10.1126/sciimmunol.adh3455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.adh3455</ArticleId><ArticleId IdType="pmc">PMC10468758</ArticleId><ArticleId IdType="pubmed">37146127</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehmer T.K., Kompaniyets L., Lavery A.M., Hsu J., Ko J.Y., Yusuf H., Romano S.D., Gundlapalli A.V., Oster M.E., Harris A.M. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data-United States, March 2020-January 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1228&#x2013;1232. doi: 10.15585/mmwr.mm7035e5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7035e5</ArticleId><ArticleId IdType="pmc">PMC8422872</ArticleId><ArticleId IdType="pubmed">34473684</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia J., Jaladanki S., Rivas-Lasarte M., Cagliostro M., Gupta A., Joshi A., Ting P., Mitter S.S., Bagiella E., Mancini D., et al. New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19. J. Am. Coll. Cardiol. 2021;77:2260&#x2013;2262. doi: 10.1016/j.jacc.2021.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.03.006</ArticleId><ArticleId IdType="pmc">PMC8074874</ArticleId><ArticleId IdType="pubmed">33926664</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Zhu H., Yang Z., Tang D., Huang L., Xia L. Tissue Characterization by Mapping and Strain Cardiac MRI to Evaluate Myocardial Inflammation in Fulminant Myocarditis. J. Magn. Reson. Imaging. 2020;52:930&#x2013;938. doi: 10.1002/jmri.27094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27094</ArticleId><ArticleId IdType="pubmed">32080960</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinojar R., Varma N., Child N., Goodman B., Jabbour A., Yu C.Y., Gebker R., Doltra A., Kelle S., Khan S., et al. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ. Cardiovasc. Imaging. 2015;8:e003285. doi: 10.1161/CIRCIMAGING.115.003285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.115.003285</ArticleId><ArticleId IdType="pubmed">26659373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li R., Zhou Z., Jiang H., Yan Z., Tao X., Li H., Xu L. Cardiac involvement in COVID-19 patients: Mid-term follow up by cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 2021;23:14. doi: 10.1186/s12968-021-00710-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00710-x</ArticleId><ArticleId IdType="pmc">PMC7904320</ArticleId><ArticleId IdType="pubmed">33627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi R., Basile M., Salzillo C., Grieco D.L., Caff&#xe8; A., Masciocchi C., Lilli L., Damiani A., La Vecchia G., Iannaccone G., et al. Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors. J. Clin. Med. 2022;11:5964. doi: 10.3390/jcm11195964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195964</ArticleId><ArticleId IdType="pmc">PMC9573406</ArticleId><ArticleId IdType="pubmed">36233830</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Wu D., Yan W., Wang X., Zhang X., Ma K., Chen H., Zeng Z., Qin Y., Wang H., et al. Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2022;74:1953. doi: 10.1093/cid/ciab703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab703</ArticleId><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Seecheran R., Narayansingh R., Giddings S., Rampaul M., Furlonge K., Abdool K., Bhagwandass N., Seecheran N.A. Atrial Arrhythmias in a Patient Presenting with Coronavirus Disease-2019 (COVID-19) Infection. J. Investig. Med. High Impact Case Rep. 2020;8:1&#x2013;6. doi: 10.1177/2324709620925571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709620925571</ArticleId><ArticleId IdType="pmc">PMC7218462</ArticleId><ArticleId IdType="pubmed">32370558</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K., Marelli-Berg F.M., Madhur M.S., Tomaszewski M., Maffia P., D&#x2019;Acquisto F., et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi R.M., Adamo M., Lupi L., Cani D.S., Di Pasquale M., Tomasoni D., Italia L., Zaccone G., Tedino C., Fabbricatore D., et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur. Heart J. 2020;41:1821&#x2013;1829. doi: 10.1093/eurheartj/ehaa388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa388</ArticleId><ArticleId IdType="pmc">PMC7239204</ArticleId><ArticleId IdType="pubmed">32383763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus&#x2013;Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Colon C.M., Barrios J.G., Chiles J.W., McElwee S.K., Russell D.W., Maddox W.R., Kay G.N. Atrial Arrhythmias in COVID-19 Patients. JACC Clin. Electrophysiol. 2020;6:1189&#x2013;1190. doi: 10.1016/j.jacep.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7253953</ArticleId><ArticleId IdType="pubmed">32972558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., Pillai R., Channon K.M., Casadei B. A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation. Circ. Res. 2005;97:629&#x2013;636. doi: 10.1161/01.RES.0000183735.09871.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000183735.09871.61</ArticleId><ArticleId IdType="pubmed">16123335</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C., Liu Z., Zhu Y., Lu J., Ge C., Zhang C., Li N., Jin N., Li Y., Tian M., et al. SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment. Front. Microbiol. 2022;12:780768. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Muszy&#x144;ski P., Bonda T.A. Mitochondrial Dysfunction in Atrial Fibrillation&#x2014;Mechanisms and Pharmacological Interventions. J. Clin. Med. 2021;10:2385. doi: 10.3390/jcm10112385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112385</ArticleId><ArticleId IdType="pmc">PMC8199309</ArticleId><ArticleId IdType="pubmed">34071563</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Wang K., Viveiros A., Kellner M.J., Penninger J.M. Angiotensin-converting enzyme 2&#x2014;At the heart of the COVID-19 pandemic. Cell. 2023;186:906&#x2013;922. doi: 10.1016/j.cell.2023.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.01.039</ArticleId><ArticleId IdType="pmc">PMC9892333</ArticleId><ArticleId IdType="pubmed">36787743</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakovac H., Feren&#x10d;i&#x107; A., Stemberger C., Mohar Vitezi&#x107; B., Cuculi&#x107; D. Detection of SARS-CoV-2 Antigens in the AV-Node of a Cardiac Conduction System-A Case Report. Trop. Med. Infect. Dis. 2022;7:43. doi: 10.3390/tropicalmed7030043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7030043</ArticleId><ArticleId IdType="pmc">PMC8955572</ArticleId><ArticleId IdType="pubmed">35324590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A.J., Moraes P.L., Foureaux G., Andrade A.B., Santos R.A.S., Almeida A.P. The angiotensin-(1-7)/Mas receptor axis is expressed in sinoatrial node cells of rats. J. Histochem. Cytochem. 2011;59:761&#x2013;768. doi: 10.1369/0022155411411712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155411411712</ArticleId><ArticleId IdType="pmc">PMC3261602</ArticleId><ArticleId IdType="pubmed">21606202</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe1;dasy G.L., Balla A., Cojocaru E., Cojocaru C., Vlad C.-E., Eva L. Role of the Renin-Angiotensin System in Long COVID&#x2019;s Cardiovascular Injuries. Biomed. 2023;11:2004. doi: 10.3390/BIOMEDICINES11072004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES11072004</ArticleId><ArticleId IdType="pmc">PMC10377338</ArticleId><ArticleId IdType="pubmed">37509643</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S., Harb J., Rima M., Annweiler C., Wu Y., Cao Z., Khattar Z.A., Legros C., Kovacic H., Fajloun Z., et al. The Pathophysiology of Long COVID throughout the Renin-Angiotensin System. Molecules. 2022;27:2903. doi: 10.3390/molecules27092903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter R.M., Young M.K., Petri W.A.O., Lyons G.R., Gilchrist C., Carey R.M., Petri W.A. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation. mSphere. 2022;7:e0022022. doi: 10.1128/msphere.00220-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00220-22</ArticleId><ArticleId IdType="pmc">PMC9429950</ArticleId><ArticleId IdType="pubmed">35913134</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone E., Kiat H., McLachlan C.S. Atrial fibrillation in COVID-19: A review of possible mechanisms. FASEB J. 2020;34:11347&#x2013;11354. doi: 10.1096/fj.202001613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001613</ArticleId><ArticleId IdType="pubmed">33078484</ArticleId></ArticleIdList></Reference><Reference><Citation>Disertori M., Rigoni M., Pace N., Casolo G., Mas&#xe8; M., Gonzini L., Lucci D., Nollo G., Ravelli F. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. JACC Cardiovasc. Imaging. 2016;9:1046&#x2013;1055. doi: 10.1016/j.jcmg.2016.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2016.01.033</ArticleId><ArticleId IdType="pubmed">27450871</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., O&#x2019;Donnell J.S., Sharif K., Emery P., Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437&#x2013;e445. doi: 10.1016/S2665-9913(20)30121-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30121-1</ArticleId><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Thachil J., Iba T., Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438&#x2013;e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Panzer B., J&#xf3;zkowicz A., Kopp C.W., Gremmel T., Panzer S., Koppensteiner R. Microvascular Thrombosis as a Critical Factor in Severe COVID-19. Int. J. Mol. Sci. 2023;24:2492. doi: 10.3390/ijms24032492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032492</ArticleId><ArticleId IdType="pmc">PMC9916726</ArticleId><ArticleId IdType="pubmed">36768817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Porter J.C., Manson J.J., Isaacs J.D., Openshaw P.J.M., McInnes I.B., Summers C., Chambers R.C. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: Challenges and opportunities. Lancet Respir. Med. 2020;8:822&#x2013;830. doi: 10.1016/S2213-2600(20)30267-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30267-8</ArticleId><ArticleId IdType="pmc">PMC7834476</ArticleId><ArticleId IdType="pubmed">32559419</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojyo S., Uchida M., Tanaka K., Hasebe R., Tanaka Y., Murakami M., Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regen. 2020;40:37. doi: 10.1186/s41232-020-00146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-020-00146-3</ArticleId><ArticleId IdType="pmc">PMC7527296</ArticleId><ArticleId IdType="pubmed">33014208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019; in COVID-19. J. Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zizzo G., Cohen P.L. Imperfect storm: Is interleukin-33 the Achilles heel of COVID-19? Lancet Rheumatol. 2020;2:e779&#x2013;e790. doi: 10.1016/S2665-9913(20)30340-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30340-4</ArticleId><ArticleId IdType="pmc">PMC7546716</ArticleId><ArticleId IdType="pubmed">33073244</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wang J., Liu C., Su L., Zhang D., Fan J., Yang Y., Xiao M., Xie J., Xu Y., et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol. Med. 2020;26:97. doi: 10.1186/s10020-020-00230-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-020-00230-x</ArticleId><ArticleId IdType="pmc">PMC7594996</ArticleId><ArticleId IdType="pubmed">33121429</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z.S., Shu T., Kang L., Wu D., Zhou X., Liao B.W., Sun X.L., Zhou X., Wang Y.Y. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients. Signal Transduct. Target. Ther. 2020;5:100. doi: 10.1038/s41392-020-0211-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0211-1</ArticleId><ArticleId IdType="pmc">PMC7303571</ArticleId><ArticleId IdType="pubmed">32561706</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Benest A.V., Kruse K., Savant S., Thomas M., Laib A.M., Loos E.K., Fiedler U., Augustin H.G. Angiopoietin-2 is critical for cytokine-induced vascular leakage. PLoS ONE. 2013;8:e70459. doi: 10.1371/journal.pone.0070459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070459</ArticleId><ArticleId IdType="pmc">PMC3734283</ArticleId><ArticleId IdType="pubmed">23940579</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N.G. Cardiac fibrosis. Cardiovasc. Res. 2021;117:1450&#x2013;1488. doi: 10.1093/CVR/CVAA324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CVR/CVAA324</ArticleId><ArticleId IdType="pmc">PMC8152700</ArticleId><ArticleId IdType="pubmed">33135058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivakumar P., Gupta S., Sarkar S., Sen S. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol. Cell. Biochem. 2008;307:159&#x2013;167. doi: 10.1007/s11010-007-9595-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-007-9595-2</ArticleId><ArticleId IdType="pubmed">17849172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhoutte D., Van Almen G.C., Van Aelst L.N.L., Van Cleemput J., Droogn&#xe9; W., Jin Y., Van De Werf F., Carmeliet P., Vanhaecke J., Papageorgiou A.P., et al. Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection. Eur. Heart J. 2013;34:1930&#x2013;1941. doi: 10.1093/eurheartj/ehs375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs375</ArticleId><ArticleId IdType="pmc">PMC4051259</ArticleId><ArticleId IdType="pubmed">23139380</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhoutte D., Schellings M.W.M., G&#xf6;tte M., Swinnen M., Herias V., Wild M.K., Vestweber D., Chorianopoulos E., Cort&#xe9;s V., Rigotti A., et al. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation. 2007;115:475&#x2013;482. doi: 10.1161/CIRCULATIONAHA.106.644609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.644609</ArticleId><ArticleId IdType="pubmed">17242279</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Li L., Chen Y., Ma J., Yang Y., Aodeng S., Cui Q., Wen K., Xiao M., Xie J., et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol. Med. 2021;27:151. doi: 10.1186/s10020-021-00412-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00412-1</ArticleId><ArticleId IdType="pmc">PMC8640509</ArticleId><ArticleId IdType="pubmed">34861818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A., Osiaevi I., Buscher K., Sackarnd J., Tepasse P.R., Fobker M., K&#xfc;hn J., Braune S., G&#xf6;bel U., Th&#xf6;lking G., et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis. 2021;24:145. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Goonewardena S.N., Grushko O.G., Wells J., Herty L., Rosenson R.S., Haus J.M., Hummel S.L. Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients. Cardiovasc. Drugs Ther. 2023;37:307. doi: 10.1007/s10557-021-07288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-021-07288-7</ArticleId><ArticleId IdType="pmc">PMC8600103</ArticleId><ArticleId IdType="pubmed">34792686</ArticleId></ArticleIdList></Reference><Reference><Citation>Queisser K.A., Mellema R.A., Middleton E.A., Portier I., Manne B.K., Denorme F., Beswick E.J., Rondina M.T., Campbell R.A., Petrey A.C. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight. 2021;6 doi: 10.1172/jci.insight.147472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147472</ArticleId><ArticleId IdType="pmc">PMC8492325</ArticleId><ArticleId IdType="pubmed">34314391</ArticleId></ArticleIdList></Reference><Reference><Citation>Buijsers B., Yanginlar C., de Nooijer A., Grondman I., Maciej-Hulme M.L., Jonkman I., Janssen N.A.F., Rother N., de Graaf M., Pickkers P., et al. Increased Plasma Heparanase Activity in COVID-19 Patients. Front. Immunol. 2020;11:575047. doi: 10.3389/fimmu.2020.575047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.575047</ArticleId><ArticleId IdType="pmc">PMC7573491</ArticleId><ArticleId IdType="pubmed">33123154</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshdy A., Zaher S., Fayed H., Coghlan J.G. COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies. Front. Cardiovasc. Med. 2021;7:626975. doi: 10.3389/fcvm.2020.626975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.626975</ArticleId><ArticleId IdType="pmc">PMC7876291</ArticleId><ArticleId IdType="pubmed">33585586</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy L.C., Goligher E.C., Lawler P.R., Slutsky A.S., Zarychanski R. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ. 2020;192:E1156&#x2013;E1161. doi: 10.1503/cmaj.201240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.201240</ArticleId><ArticleId IdType="pmc">PMC7546749</ArticleId><ArticleId IdType="pubmed">32816822</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F., Vanhoorelbeke K., De Meyer S.F. von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke. Front. Immunol. 2019;10:495067. doi: 10.3389/fimmu.2019.02884.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02884</ArticleId><ArticleId IdType="pmc">PMC6928043</ArticleId><ArticleId IdType="pubmed">31921147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalagara T., Moutsis T., Yang Y., Pappelbaum K.I., Farken A., Cladder-Micus L., Vidal-Y-Sy S., John A., Bauer A.T., Moerschbacher B.M., et al. The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. Blood Adv. 2018;2:2347&#x2013;2357. doi: 10.1182/bloodadvances.2017013995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017013995</ArticleId><ArticleId IdType="pmc">PMC6156889</ArticleId><ArticleId IdType="pubmed">30237293</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton E.A., He X.-Y., Denorme F., Campbell R.A., Ng D., Salvatore S.P., Mostyka M., Baxter-Stoltzfus A., Borczuk A.C., Loda M., et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169&#x2013;1179. doi: 10.1182/blood.2020007008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007008</ArticleId><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532&#x2013;1535. doi: 10.1126/science.1092385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1092385</ArticleId><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 2018;18:134&#x2013;147. doi: 10.1038/nri.2017.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.105</ArticleId><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Martin S., Shchendrygina A., Hoffmann J., Ka M.M., Giokoglu E., Vanchin B., Holm N., Karyou A., Laux G.S., et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat. Med. 2022;28:2117&#x2013;2123. doi: 10.1038/s41591-022-02000-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Morrone M.C., Patrono C., Santoro M.G., Schiaffino S., Remuzzi G., Bussolati G., Cappuccinelli P., Fitzgerald G., Bacci M.L., et al. Long Covid: Where we stand and challenges ahead. Cell Death Differ. 2022;29:1891&#x2013;1900. doi: 10.1038/s41418-022-01052-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn A.V.W., Guy G.W., Brysch W., Bell J.D. Understanding Long COVID; Mitochondrial Health and Adaptation&#x2014;Old Pathways, New Problems. Biomedicines. 2022;10:3113. doi: 10.3390/biomedicines10123113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123113</ArticleId><ArticleId IdType="pmc">PMC9775339</ArticleId><ArticleId IdType="pubmed">36551869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian H., Watari K., Sanchez-Lopez E., Offenberger J., Onyuru J., Sampath H., Ying W., Hoffman H.M., Shadel G.S., Karin M. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55:1370&#x2013;1385.e8. doi: 10.1016/j.immuni.2022.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.007</ArticleId><ArticleId IdType="pmc">PMC9378606</ArticleId><ArticleId IdType="pubmed">35835107</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone O., Pieroni M., Rapezzi C., Olivotto I. The spectrum of myocarditis: From pathology to the clinics. Virchows Arch. 2019;475:279&#x2013;301. doi: 10.1007/s00428-019-02615-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-019-02615-8</ArticleId><ArticleId IdType="pubmed">31297595</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;oletti L., L&#xe9;v&#xea;que N., Boulagnon C., Brasselet C., Fornes P. Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 2009;102:559&#x2013;568. doi: 10.1016/j.acvd.2009.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2009.04.010</ArticleId><ArticleId IdType="pubmed">19664576</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., Schultheiss H.P. Viral Persistence in the Myocardium Is Associated with Progressive Cardiac Dysfunction. Circulation. 2005;112:1965&#x2013;1970. doi: 10.1161/CIRCULATIONAHA.105.548156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.548156</ArticleId><ArticleId IdType="pubmed">16172268</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L.T. Myocarditis. N. Engl. J. Med. 2009;360:1526&#x2013;1538. doi: 10.1056/NEJMra0800028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0800028</ArticleId><ArticleId IdType="pmc">PMC5814110</ArticleId><ArticleId IdType="pubmed">19357408</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeserich M., Brunner E., Kandolf R., Olschewski M., Kimmel S., Friedrich M.G., F&#xf6;ll D., Bode C., Geibel A. Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood. Int. J. Cardiovasc. Imaging. 2013;29:121&#x2013;129. doi: 10.1007/s10554-012-0052-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-012-0052-2</ArticleId><ArticleId IdType="pubmed">22562417</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss H.-P., Baumeier C., Aleshcheva G., Bock C.-T., Escher F. Viral Myocarditis&#x2014;From Pathophysiology to Treatment. J. Clin. Med. 2021;10:5240. doi: 10.3390/jcm10225240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225240</ArticleId><ArticleId IdType="pmc">PMC8623269</ArticleId><ArticleId IdType="pubmed">34830522</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonschot J., Hazebroek M., Merken J., Debing Y., Dennert R., Brunner-La Rocca H.P., Heymans S. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: Review of the literature. Eur. J. Heart Fail. 2016;18:1430&#x2013;1441. doi: 10.1002/ejhf.665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.665</ArticleId><ArticleId IdType="pubmed">27748022</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher F., K&#xfc;hl U., Gross U., Westermann D., Poller W., Tsch&#xf6;pe C., Lassner D., Schultheiss H.-P. Aggravation of left ventricular dysfunction in patients with biopsy-proven cardiac human herpesvirus A and B infection. J. Clin. Virol. 2015;63:1&#x2013;5. doi: 10.1016/j.jcv.2014.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.11.026</ArticleId><ArticleId IdType="pubmed">25600595</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonavita C.M., Cardin R.D. Don&#x2019;t Go Breaking My Heart: MCMV as a Model for HCMV-Associated Cardiovascular Diseases. Pathog. 2021;10:619. doi: 10.3390/pathogens10050619.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050619</ArticleId><ArticleId IdType="pmc">PMC8157551</ArticleId><ArticleId IdType="pubmed">34069957</ArticleId></ArticleIdList></Reference><Reference><Citation>Magno Palmeira M., Umemura Ribeiro H.Y., Garcia Lira Y., Machado Juc&#xe1; Neto F.O., Da Silva Rodrigues I.A., Fernandes Da Paz L.N., Nascimento Pinheiro M.D.C. Heart failure due to cytomegalovirus myocarditis in immunocompetent young adults: A case report. BMC Res. Notes. 2016;9:391. doi: 10.1186/s13104-016-2181-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-016-2181-5</ArticleId><ArticleId IdType="pmc">PMC4974773</ArticleId><ArticleId IdType="pubmed">27495246</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubille C., Brunel A.S., Gahide G., Kovacsik H.V., Le Quellec A. Cytomegalovirus (CMV) and acute myocarditis in an immunocompetent patient. Intern. Med. 2010;49:131&#x2013;133. doi: 10.2169/internalmedicine.49.2313.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.49.2313</ArticleId><ArticleId IdType="pubmed">20075576</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Panetta G.L., Piccirillo F., Spoto S., Myers J., Serino F.M., Costantino S., Di Sciascio G. Acute Epstein-Barr related myocarditis: An unusual but life-threatening disease in an immunocompetent patient. J. Cardiol. Cases. 2019;21:137&#x2013;140. doi: 10.1016/j.jccase.2019.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jccase.2019.12.001</ArticleId><ArticleId IdType="pmc">PMC7102541</ArticleId><ArticleId IdType="pubmed">32256861</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss H.P., Piper C., Sowade O., Waagstein F., Kapp J.F., Wegscheider K., Groetzbach G., Pauschinger M., Escher F., Arbustini E., et al. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-&#x3b2; treatment in patients with chronic viral cardiomyopathy. Clin. Res. Cardiol. 2016;105:763&#x2013;773. doi: 10.1007/s00392-016-0986-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-016-0986-9</ArticleId><ArticleId IdType="pubmed">27112783</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., Pham V., K&#xfc;hl U., Schwimmbeck P.L., Schultheiss H.P., Towbin J.A. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation. 1999;99:1348&#x2013;1354. doi: 10.1161/01.CIR.99.10.1348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.10.1348</ArticleId><ArticleId IdType="pubmed">10077520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyas S.Z., Tabassum R., Hamed H., Rehman S.U., Qadri I. Hepatitis C Virus-Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy-Related Cardiopulmonary Toxicity. Viral Immunol. 2017;30:633&#x2013;641. doi: 10.1089/vim.2017.0009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2017.0009</ArticleId><ArticleId IdType="pubmed">28953449</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumori A., Matoba Y., Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation. 1995;92:2519&#x2013;2525. doi: 10.1161/01.CIR.92.9.2519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.9.2519</ArticleId><ArticleId IdType="pubmed">7586353</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumori A., Shimada T., Chapman N.M., Tracy S.M., Mason J.W. Myocarditis and heart failure associated with hepatitis C virus infection. J. Card. Fail. 2006;12:293&#x2013;298. doi: 10.1016/j.cardfail.2005.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2005.11.004</ArticleId><ArticleId IdType="pubmed">16679263</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathez G., Cagno V. Viruses Like Sugars: How to Assess Glycan Involvement in Viral Attachment. Microorganisms. 2021;9:1238. doi: 10.3390/microorganisms9061238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061238</ArticleId><ArticleId IdType="pmc">PMC8230229</ArticleId><ArticleId IdType="pubmed">34200288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V., Tseligka E.D., Jones S.T., Tapparel C. Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? Viruses. 2019;11:596. doi: 10.3390/v11070596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070596</ArticleId><ArticleId IdType="pmc">PMC6669472</ArticleId><ArticleId IdType="pubmed">31266258</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles R.J., Fahrner J.A., Petrella J.M., Boucher R.C., Bergelson J.M. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J. Virol. 2000;74:6050&#x2013;6057. doi: 10.1128/JVI.74.13.6050-6057.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.13.6050-6057.2000</ArticleId><ArticleId IdType="pmc">PMC112103</ArticleId><ArticleId IdType="pubmed">10846088</ArticleId></ArticleIdList></Reference><Reference><Citation>Targosz-Korecka M., Kubisiak A., Kloska D., Kopacz A., Grochot-Przeczek A., Szymonski M. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors. Sci. Rep. 2021;11:12157. doi: 10.1038/s41598-021-91231-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91231-1</ArticleId><ArticleId IdType="pmc">PMC8190434</ArticleId><ArticleId IdType="pubmed">34108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Liu L., Wang Y. Viral proteins recognized by different TLRs. J. Med. Virol. 2021;93:6116&#x2013;6123. doi: 10.1002/jmv.27265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27265</ArticleId><ArticleId IdType="pubmed">34375002</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J. Med. Virol. 2020;92:2105&#x2013;2113. doi: 10.1002/jmv.25987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25987</ArticleId><ArticleId IdType="pmc">PMC7267663</ArticleId><ArticleId IdType="pubmed">32383269</ArticleId></ArticleIdList></Reference><Reference><Citation>Katare P.B., Nizami H.L., Paramesha B., Dinda A.K., Banerjee S.K. Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation. Sci. Rep. 2020;10:19232. doi: 10.1038/s41598-020-75301-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75301-4</ArticleId><ArticleId IdType="pmc">PMC7648754</ArticleId><ArticleId IdType="pubmed">33159115</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F.S., Marchant D., Hendry R., Luo H., Yang D., Ye X., Shi J., McManus B.M. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10:629&#x2013;653. doi: 10.2217/fmb.15.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu T.C., Wu W.J., Chen M.C., Tsay G.J. Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand. J. Infect. Dis. 2004;36:570&#x2013;577. doi: 10.1080/00365540410016230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365540410016230</ArticleId><ArticleId IdType="pubmed">15370668</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachelier K., Biehl S., Schwarz V., Kindermann I., Kandolf R., Sauter M., Ukena C., Yilmaz A., Sliwa K., Bock C.-T., et al. Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles. PLoS ONE. 2017;12:e0176311. doi: 10.1371/journal.pone.0176311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0176311</ArticleId><ArticleId IdType="pmc">PMC5439674</ArticleId><ArticleId IdType="pubmed">28531186</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallbracht K.B., Schwimmbeck P.L., K&#xfc;hl U., Seeberg B., Schultheiss H.P. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation. 2004;110:2938&#x2013;2945. doi: 10.1161/01.CIR.0000146891.31481.CF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000146891.31481.CF</ArticleId><ArticleId IdType="pubmed">15505098</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkin M.N., Uriel N. Heart health in the age of highly active antiretroviral therapy: A review of HIV cardiomyopathy. Curr. Opin. Cardiol. 2018;33:317&#x2013;324. doi: 10.1097/HCO.0000000000000513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000513</ArticleId><ArticleId IdType="pubmed">29543672</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumori A., Yamada T., Suzuki H., Matoba Y., Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Heart. 1994;72:561&#x2013;566. doi: 10.1136/hrt.72.6.561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.72.6.561</ArticleId><ArticleId IdType="pmc">PMC1025643</ArticleId><ArticleId IdType="pubmed">7857740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai C. From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death. Circulation. 1999;99:1091&#x2013;1100. doi: 10.1161/01.CIR.99.8.1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.8.1091</ArticleId><ArticleId IdType="pubmed">10051305</ArticleId></ArticleIdList></Reference><Reference><Citation>Neu C., Thiele Y., Horr F., Beckers C., Frank N., Marx G., Martin L., Kraemer S., Zechendorf E. DAMPs Released from Proinflammatory Macrophages Induce Inflammation in Cardiomyocytes via Activation of TLR4 and TNFR. Int. J. Mol. Sci. 2022;23:15522. doi: 10.3390/ijms232415522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415522</ArticleId><ArticleId IdType="pmc">PMC9778802</ArticleId><ArticleId IdType="pubmed">36555168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavine K.J., Pinto A.R., Epelman S., Kopecky B.J., Clemente-Casares X., Godwin J., Rosenthal N., Kovacic J.C. The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series. J. Am. Coll. Cardiol. 2018;72:2213. doi: 10.1016/j.jacc.2018.08.2149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.2149</ArticleId><ArticleId IdType="pmc">PMC6209119</ArticleId><ArticleId IdType="pubmed">30360829</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani J.W., Suk Danik H.J., Dec G.W., DiSalvo T.G. Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am. Heart J. 2006;151:463&#x2013;470. doi: 10.1016/j.ahj.2005.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2005.03.037</ArticleId><ArticleId IdType="pubmed">16442915</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman A.M., McNamara D. Myocarditis. N. Engl. J. Med. 2000;343:1388&#x2013;1398. doi: 10.1056/NEJM200011093431908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200011093431908</ArticleId><ArticleId IdType="pubmed">11070105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragoza C., Ocampo C., Saura M., Leppo M., Wei X.Q., Quick R., Moncada S., Liew F.Y., Lowenstein C.J. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc. Natl. Acad. Sci. USA. 1998;95:2469&#x2013;2474. doi: 10.1073/pnas.95.5.2469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.5.2469</ArticleId><ArticleId IdType="pmc">PMC19377</ArticleId><ArticleId IdType="pubmed">9482909</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U., Lassner D., Pauschinger M., Gross U.M., Seeberg B., Noutsias M., Poller W., Schultheiss H.P. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J. Med. Virol. 2008;80:1243&#x2013;1251. doi: 10.1002/jmv.21187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21187</ArticleId><ArticleId IdType="pubmed">18461615</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., Poller W., Kandolf R., Schultheiss H.P. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with &#x201c;idiopathic&#x201d; left ventricular dysfunction. Circulation. 2005;111:887&#x2013;893. doi: 10.1161/01.CIR.0000155616.07901.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000155616.07901.35</ArticleId><ArticleId IdType="pubmed">15699250</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U., Lassner D., Von Schlippenbach J., Poller W., Schultheiss H.P. Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. J. Am. Coll. Cardiol. 2012;60:1295&#x2013;1296. doi: 10.1016/j.jacc.2012.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.06.026</ArticleId><ArticleId IdType="pubmed">23017536</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauschinger M., Doerner A., Kuehl U., Schwimmbeck P.L., Poller W., Kandolf R., Schultheiss H.P. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation. 1999;99:889&#x2013;895. doi: 10.1161/01.CIR.99.7.889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.7.889</ArticleId><ArticleId IdType="pubmed">10027811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietsch H., Escher F., Aleshcheva G., Lassner D., Bock C.T., Schultheiss H.P. Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure. Sci. Rep. 2020;10:22354. doi: 10.1038/s41598-020-78597-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78597-4</ArticleId><ArticleId IdType="pmc">PMC7749156</ArticleId><ArticleId IdType="pubmed">33339949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl U., Lassner D., Dorner A., Rohde M., Escher F., Seeberg B., Hertel E., Tschope C., Skurk C., Gross U.M., et al. A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression. Basic Res. Cardiol. 2013;108:372. doi: 10.1007/s00395-013-0372-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-013-0372-y</ArticleId><ArticleId IdType="pubmed">23934091</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D.L., Frisancho-Kiss S., Rose N.R. Viruses as adjuvants for autoimmunity: Evidence from Coxsackievirus-induced myocarditis. Rev. Med. Virol. 2005;15:17&#x2013;27. doi: 10.1002/rmv.445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.445</ArticleId><ArticleId IdType="pubmed">15386590</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 2008;3:127&#x2013;155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S.A. Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis. Curr. Pharm. Des. 2016;22:408&#x2013;426. doi: 10.2174/1381612822666151222160500.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151222160500</ArticleId><ArticleId IdType="pubmed">26696257</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose N.R. Viral myocarditis. Curr. Opin. Rheumatol. 2016;28:383&#x2013;389. doi: 10.1097/BOR.0000000000000303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000303</ArticleId><ArticleId IdType="pmc">PMC4948180</ArticleId><ArticleId IdType="pubmed">27166925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracamonte-Baran W., &#x10c;ih&#xe1;kov&#xe1; D. Cardiac Autoimmunity: Myocarditis. Adv. Exp. Med. Biol. 2017;1003:187&#x2013;221. doi: 10.1007/978-3-319-57613-8_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-57613-8_10</ArticleId><ArticleId IdType="pmc">PMC5706653</ArticleId><ArticleId IdType="pubmed">28667560</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.W. T cell mimicry in inflammatory heart disease. Mol. Immunol. 2004;40:1121&#x2013;1127. doi: 10.1016/j.molimm.2003.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2003.11.023</ArticleId><ArticleId IdType="pubmed">15036918</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamm C., Fairweather D.L., Cooper L.T. Republished: Pathogenesis and diagnosis of myocarditis. Postgrad. Med. J. 2012;88:539&#x2013;544. doi: 10.1136/postgradmedj-2012-301686rep.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2012-301686rep</ArticleId><ArticleId IdType="pmc">PMC5813801</ArticleId><ArticleId IdType="pubmed">22904235</ArticleId></ArticleIdList></Reference><Reference><Citation>Monda E., Palmiero G., Rubino M., Verrillo F., Amodio F., Di Fraia F., Pacileo R., Fimiani F., Esposito A., Cirillo A., et al. Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies. Int. J. Mol. Sci. 2020;21:6462. doi: 10.3390/ijms21186462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186462</ArticleId><ArticleId IdType="pmc">PMC7554875</ArticleId><ArticleId IdType="pubmed">32899712</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymans S., Eriksson U., Lehtonen J., Cooper L.T. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. J. Am. Coll. Cardiol. 2016;68:2348&#x2013;2364. doi: 10.1016/j.jacc.2016.09.937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.09.937</ArticleId><ArticleId IdType="pubmed">27884253</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann D., Lindner D., Kasner M., Zietsch C., Savvatis K., Escher F., Von Schlippenbach J., Skurk C., Steendijk P., Riad A., et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ. Heart Fail. 2011;4:44&#x2013;52. doi: 10.1161/CIRCHEARTFAILURE.109.931451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.109.931451</ArticleId><ArticleId IdType="pubmed">21075869</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L.Y., Halder S., Agbandje-Mckenna M. Parvovirus glycan interactions. Curr. Opin. Virol. 2014;7:108&#x2013;118. doi: 10.1016/j.coviro.2014.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.05.007</ArticleId><ArticleId IdType="pmc">PMC4149944</ArticleId><ArticleId IdType="pubmed">25047752</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti C., Cirone M., Sgro R., Altieri F., Zompetta C., Faggioni A. Early interactions of human herpesvirus 6 with lymphoid cells: Role of membrane protein components and glycosaminoglycans in virus binding. J. Med. Virol. 2000;62:487&#x2013;497. doi: 10.1002/1096-9071(200012)62:4&lt;487::AID-JMV14&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200012)62:4&lt;487::AID-JMV14&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">11074478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadigal S., Koganti R., Yadavalli T., Agelidis A., Suryawanshi R., Shukla D. Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress. J. Virol. 2020;94 doi: 10.1128/JVI.01672-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01672-19</ArticleId><ArticleId IdType="pmc">PMC7158720</ArticleId><ArticleId IdType="pubmed">31827001</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly S.A., Jardetzky T.S., Longnecker R. The structural basis of herpesvirus entry. Nat. Rev. Microbiol. 2021;19:110. doi: 10.1038/s41579-020-00448-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00448-w</ArticleId><ArticleId IdType="pmc">PMC8579738</ArticleId><ArticleId IdType="pubmed">33087881</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuhlmeier K.M. Hyaluronan production in synoviocytes as a consequence of viral infections: HAS1 activation by Epstein-Barr virus and synthetic double- and single-stranded viral RNA analogs. J. Biol. Chem. 2008;283:16781&#x2013;16789. doi: 10.1074/jbc.M801669200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M801669200</ArticleId><ArticleId IdType="pubmed">18400745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra D., Hasan M.H., Bates J.T., Bierdeman M.A., Ederer D.R., Parmar R.C., Fassero L.A., Liang Q., Qiu H., Tiwari V., et al. The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells. PLoS Pathog. 2021;17:e1009803. doi: 10.1371/journal.ppat.1009803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009803</ArticleId><ArticleId IdType="pmc">PMC8384199</ArticleId><ArticleId IdType="pubmed">34352038</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton T., Nowlin D.M., Cooper N.R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology. 1993;193:834&#x2013;841. doi: 10.1006/viro.1993.1192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1993.1192</ArticleId><ArticleId IdType="pubmed">8384757</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeish N.J., Williams &#xc7;.H., Kaloudas D., Roivainen M.M., Stanway G. Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J. Virol. 2012;86:11163&#x2013;11170. doi: 10.1128/JVI.00640-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00640-12</ArticleId><ArticleId IdType="pmc">PMC3457184</ArticleId><ArticleId IdType="pubmed">22855495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Poh C.L., Sam I.-C., Chan Y.F. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013;87:611&#x2013;620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J. Biomed. Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Mart&#xed;nez I.E., Ramos-Mart&#xed;nez E., Segura-Vel&#xe1;zquez R.&#xc1;., Saavedra-Monta&#xf1;ez M., Cervantes-Torres J.B., Cerb&#xf3;n M., Papy-Garcia D., Zenteno E., S&#xe1;nchez-Betancourt J.I. Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin? Int. J. Mol. Sci. 2022;23:9842. doi: 10.3390/ijms23179842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23179842</ArticleId><ArticleId IdType="pmc">PMC9456526</ArticleId><ArticleId IdType="pubmed">36077240</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;er K., Alshawabkeh M., Schellhorn S., Bronder K., Zhang W., Ehrhardt A. Influence of Heparan Sulfate Proteoglycans and Factor X on species D Human Adenovirus Uptake and Transduction. Viruses. 2022;15:55. doi: 10.3390/v15010055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010055</ArticleId><ArticleId IdType="pmc">PMC9866072</ArticleId><ArticleId IdType="pubmed">36680095</ArticleId></ArticleIdList></Reference><Reference><Citation>Fender P., Schoehn G., Perron-Sierra F., Tucker G.C., Lortat-Jacob H. Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle. Virology. 2008;371:155&#x2013;164. doi: 10.1016/j.virol.2007.09.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.09.026</ArticleId><ArticleId IdType="pubmed">17950396</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigorov B., Reungoat E., Gentil dit Maurin A., Varbanov M., Blaising J., Michelet M., Manuel R., Parent R., Bartosch B., Zoulim F., et al. Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. Cell. Microbiol. 2017;19:e12711. doi: 10.1111/cmi.12711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12711</ArticleId><ArticleId IdType="pubmed">27930836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Sodroski C., Cha H., Li Q., Liang T.J. Infection of Hepatocytes with HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7. Gastroenterology. 2017;152:257&#x2013;270.e7. doi: 10.1053/j.gastro.2016.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.09.033</ArticleId><ArticleId IdType="pmc">PMC5547743</ArticleId><ArticleId IdType="pubmed">27693511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerezo-Maga&#xf1;a M., B&#xe5;ng-Rudenstam A., Belting M. Proteoglycans: A common portal for SARS-CoV-2 and extracellular vesicle uptake. Am. J. Physiol. Cell Physiol. 2023;324:C76&#x2013;C84. doi: 10.1152/ajpcell.00453.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00453.2022</ArticleId><ArticleId IdType="pmc">PMC9799137</ArticleId><ArticleId IdType="pubmed">36458979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell T.J., Brand O.J., Morgan D.J., Salek-Ardakani S., Jagger C., Fujimori T., Cholewa L., Tilakaratna V., &#xd6;stling J., Thomas M., et al. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix Biol. 2019;80:14&#x2013;28. doi: 10.1016/j.matbio.2018.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2018.06.006</ArticleId><ArticleId IdType="pmc">PMC6548309</ArticleId><ArticleId IdType="pubmed">29933044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasupathy S., Tavella R., Grover S., Raman B., Procter N.E.K., Du Y.T., Mahadavan G., Stafford I., Heresztyn T., Holmes A., et al. Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]) Circulation. 2017;136:894&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634219</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D., Basso C., Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc. Res. 2001;50:399&#x2013;408. doi: 10.1016/S0008-6363(01)00254-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(01)00254-1</ArticleId><ArticleId IdType="pubmed">11334844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;pe C., Ammirati E., Bozkurt B., Caforio A.L.P.P., Cooper L.T., Felix S.B., Hare J.M., Heidecker B., Heymans S., H&#xfc;bner N., et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nat. Rev. Cardiol. 2021;18:169&#x2013;193. doi: 10.1038/s41569-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Baksi A.J., Kanaganayagam G.S., Prasad S.K. Arrhythmias in viral myocarditis and pericarditis. Card. Electrophysiol. Clin. 2015;7:269&#x2013;281. doi: 10.1016/j.ccep.2015.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2015.03.009</ArticleId><ArticleId IdType="pubmed">26002391</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretto G., Sala S., Rizzo S., Palmisano A., Esposito A., De Cobelli F., Campochiaro C., De Luca G., Foppoli L., Dagna L., et al. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships with Myocardial Inflammation. J. Am. Coll. Cardiol. 2020;75:1046&#x2013;1057. doi: 10.1016/j.jacc.2020.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.01.036</ArticleId><ArticleId IdType="pubmed">32138965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira V.M., Piechnik S.K., Dall&#x2019;Armellina E., Karamitsos T.D., Francis J.M., Ntusi N., Holloway C., Choudhury R.P., Kardos A., Robson M.D., et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J. Cardiovasc. Magn. Reson. 2014;16:36. doi: 10.1186/1532-429X-16-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-16-36</ArticleId><ArticleId IdType="pmc">PMC4041901</ArticleId><ArticleId IdType="pubmed">24886708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E., Moroni F., Sormani P., Peritore A., Milazzo A., Quattrocchi G., Cipriani M., Oliva F., Giannattasio C., Frigerio M., et al. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis. Int. J. Cardiol. 2017;231:216&#x2013;221. doi: 10.1016/j.ijcard.2016.11.282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.11.282</ArticleId><ArticleId IdType="pubmed">27913009</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J.L., Jensen H.K., Peel S.A., Chiribiri A., Grondal A.K., Bloch L.O., Pedersen S.F., Bentzon J.F., Kolbitsch C., Karim R., et al. Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: A histological validation study. Eur. Heart J. 2014;35:1486&#x2013;1495. doi: 10.1093/eurheartj/eht560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht560</ArticleId><ArticleId IdType="pmc">PMC4048535</ArticleId><ArticleId IdType="pubmed">24419806</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickfeld T., Tian J., Ahmad G., Jimenez A., Turgeman A., Kuk R., Peters M., Saliaris A., Saba M., Shorofsky S., et al. MRI-Guided ventricular tachycardia ablation: Integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ. Arrhythm. Electrophysiol. 2011;4:172&#x2013;184. doi: 10.1161/CIRCEP.110.958744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.110.958744</ArticleId><ArticleId IdType="pubmed">21270103</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Armenta J., Berruezo A., Andreu D., Camara O., Silva E., Serra L., Barbarito V., Carotenutto L., Evertz R., Ortiz-P&#xe9;rez J.T., et al. Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR: Insights for ventricular tachycardia ablation. Circ. Arrhythm. Electrophysiol. 2013;6:528&#x2013;537. doi: 10.1161/CIRCEP.113.000264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.113.000264</ArticleId><ArticleId IdType="pubmed">23685537</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-David E., Arenal &#xc1;., Rubio-Guivernau J.L., Del Castillo R., Atea L., Arbelo E., Caballero E., Celorrio V., Datino T., Gonzalez-Torrecilla E., et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: Comparison of signal intensity scar mapping and endocardial voltage mappin. J. Am. Coll. Cardiol. 2011;57:184&#x2013;194. doi: 10.1016/j.jacc.2010.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.07.043</ArticleId><ArticleId IdType="pubmed">21211689</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeppenfeld K., Tfelt-Hansen J., de Riva M., Winkel B.G., Behr E.R., Blom N.A., Charron P., Corrado D., Dagres N., de Chillou C., et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed by the task force for the management of patients with death of the European Society of Cardiology (ESC) Endorsed by the. Eur. Heart J. 2022;43:3997&#x2013;4126. doi: 10.1093/eurheartj/ehac262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac262</ArticleId><ArticleId IdType="pubmed">36017572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai T., Inomata T., Kohno T., Asaumi Y., Fujino T., Ikeda Y., Kubo T., Matsuura H., Nakamura K., Okumura T., et al. JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis. Circ. J. 2023;87:674&#x2013;754. doi: 10.1253/circj.CJ-22-0696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-22-0696</ArticleId><ArticleId IdType="pubmed">36908170</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990&#x2013;2019. J. Am. Coll. Cardiol. 2020;76:2982&#x2013;3021. doi: 10.1016/j.jacc.2020.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolfo D., Collini V., Sinagra G. Advanced Heart Failure in Special Population: Cardiomyopathies and Myocarditis. Heart Fail. Clin. 2021;17:661&#x2013;672. doi: 10.1016/j.hfc.2021.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hfc.2021.05.010</ArticleId><ArticleId IdType="pubmed">34511213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi M., Banfi C., Grinberg D., Koffel C., Bendjelid K., Robin J., Giraud R., Obadia J.F. Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients. J. Thorac. Dis. 2016;8:E495. doi: 10.21037/jtd.2016.06.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.06.26</ArticleId><ArticleId IdType="pmc">PMC4958873</ArticleId><ArticleId IdType="pubmed">27499982</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A., Price S., Slutsky A.S., Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020;396:199&#x2013;212. doi: 10.1016/S0140-6736(20)31047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31047-3</ArticleId><ArticleId IdType="pubmed">32682486</ArticleId></ArticleIdList></Reference><Reference><Citation>Means R.T. The anaemia of infection. Baillieres. Best Pract. Res. Clin. Haematol. 2000;13:151&#x2013;162. doi: 10.1053/beha.1999.0065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/beha.1999.0065</ArticleId><ArticleId IdType="pubmed">10942618</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler R., Lanser L., Barket R., Rangger L., Schapfl A., Schaber M., Fritsche G., W&#xf6;ll E., Weiss G. Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection. J. Clin. Med. 2020;9:2429. doi: 10.3390/jcm9082429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082429</ArticleId><ArticleId IdType="pmc">PMC7464087</ArticleId><ArticleId IdType="pubmed">32751400</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G., Kirtane A.J., Baber U., G&#xe9;n&#xe9;reux P., Witzenbichler B., Neumann F.J., Weisz G., Maehara A., Rinaldi M.J., Metzger C., et al. Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study. Am. J. Cardiol. 2016;117:1877&#x2013;1883. doi: 10.1016/j.amjcard.2016.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2016.03.034</ArticleId><ArticleId IdType="pubmed">27131611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Kopp C.W., Koppensteiner R., Lang I.M., Pultar J., Lee S., Weikert C., Panzer S., Gremmel T. Decreased platelet inhibition by P2Y12 receptor blockers in anaemia. Eur. J. Clin. Investig. 2018;48:e12861. doi: 10.1111/eci.12861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12861</ArticleId><ArticleId IdType="pubmed">29171876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E., Bizzi E., Veronese G., Groh M., Van de Heyning C.M., Lehtonen J., de Chambrun M.P., Cereda A., Picchi C., Trotta L., et al. Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis. Front. Med. 2022;9:838564. doi: 10.3389/fmed.2022.838564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.838564</ArticleId><ArticleId IdType="pmc">PMC8958011</ArticleId><ArticleId IdType="pubmed">35350578</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss H.P., Khl U., Cooper L.T. The management of myocarditis. Eur. Heart J. 2011;32:2616&#x2013;2625. doi: 10.1093/eurheartj/ehr165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr165</ArticleId><ArticleId IdType="pubmed">21705357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampejo T., Durkin S.M., Bhatt N., Guttmann O. Acute myocarditis: Aetiology, diagnosis and management. Clin. Med. 2021;21:e505. doi: 10.7861/clinmed.2021-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0121</ArticleId><ArticleId IdType="pmc">PMC8439515</ArticleId><ArticleId IdType="pubmed">34507935</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang V., Ganatra S., Shah S.P., Dani S.S., Neilan T.G., Thavendiranathan P., Resnic F.S., Piemonte T.C., Barac A., Patel R., et al. Management of Patients with Giant Cell Myocarditis: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2021;77:1122&#x2013;1134. doi: 10.1016/j.jacc.2020.11.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.074</ArticleId><ArticleId IdType="pubmed">33632487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer P.C., Sheng C.C., Sahoo D., Dugar S., Prada R.A., Wang T.K.M., Abou Hassan O.K., Hernandez-Montfort J., Wolinsky D.A., Culver D.A., et al. Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. Eur. Heart J. Open. 2021;1:oeab002. doi: 10.1093/ehjopen/oeab002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjopen/oeab002</ArticleId><ArticleId IdType="pmc">PMC9242054</ArticleId><ArticleId IdType="pubmed">35923169</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Zhou Z., Zheng Y., Yang S., Huang K., Li H. Roles of inflammasomes in viral myocarditis. Front. Cell. Infect. Microbiol. 2023;13:1149911. doi: 10.3389/fcimb.2023.1149911.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1149911</ArticleId><ArticleId IdType="pmc">PMC10225676</ArticleId><ArticleId IdType="pubmed">37256114</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veerdonk F.L., Giamarellos-Bourboulis E., Pickkers P., Derde L., Leavis H., van Crevel R., Engel J.J., Wiersinga W.J., Vlaar A.P.J., Shankar-Hari M., et al. A guide to immunotherapy for COVID-19. Nat. Med. 2022;28:39&#x2013;50. doi: 10.1038/s41591-021-01643-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01643-9</ArticleId><ArticleId IdType="pubmed">35064248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E., Frigerio M., Adler E.D., Basso C., Birnie D.H., Brambatti M., Friedrich M.G., Klingel K., Lehtonen J., Moslehi J.J., et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ. Heart Fail. 2020;13:e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.007405</ArticleId><ArticleId IdType="pmc">PMC7673642</ArticleId><ArticleId IdType="pubmed">33176455</ArticleId></ArticleIdList></Reference><Reference><Citation>Merken J., Hazebroek M., Van Paassen P., Verdonschot J., Van Empel V., Knackstedt C., Abdul Hamid M., Seiler M., Kolb J., Hoermann P., et al. Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients with Virus-Negative Nonfulminant Inflammatory Cardiomyopathy. Circ. Heart Fail. 2018;11:e004228. doi: 10.1161/CIRCHEARTFAILURE.117.004228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.117.004228</ArticleId><ArticleId IdType="pubmed">29449368</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretto G., Sala S., De Luca G., Marcolongo R., Campochiaro C., Sartorelli S., Tresoldi M., Foppoli L., Palmisano A., Esposito A., et al. Immunosuppressive Therapy and Risk Stratification of Patients with Myocarditis Presenting with Ventricular Arrhythmias. JACC Clin. Electrophysiol. 2020;6:1221&#x2013;1234. doi: 10.1016/j.jacep.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.05.013</ArticleId><ArticleId IdType="pubmed">33092747</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernethy A., Raza S., Sun J.L., Anstrom K.J., Tracy R., Steiner J., VanBuren P., LeWinter M.M. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure with Preserved Ejection Fraction. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2018;7:e007385. doi: 10.1161/JAHA.117.007385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.007385</ArticleId><ArticleId IdType="pmc">PMC6015440</ArticleId><ArticleId IdType="pubmed">29650706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijk S.S.-V., Van Empel V., Davarzani N., Maeder M.T., Handschin R., Pfisterer M.E., Rocca H.P.B.-L. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction. Eur. J. Heart Fail. 2015;17:1006&#x2013;1014. doi: 10.1002/ejhf.414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.414</ArticleId><ArticleId IdType="pubmed">26472682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna A., Frangogiannis N.G. Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure. Cardiovasc. Drugs Ther. 2020;34:849. doi: 10.1007/s10557-020-07071-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-020-07071-0</ArticleId><ArticleId IdType="pmc">PMC7479403</ArticleId><ArticleId IdType="pubmed">32902739</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj N.S., Gupta K., Gharpure N., Pate M., Chopra L., Kalra R., Prabhu S.D. Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: A quantitative synthesis of the literature. ESC Heart Fail. 2020;7:1319&#x2013;1330. doi: 10.1002/ehf2.12681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12681</ArticleId><ArticleId IdType="pmc">PMC7261557</ArticleId><ArticleId IdType="pubmed">32198851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.L., McMurray J.J.V., Packer M., Swedberg K., Borer J.S., Colucci W.S., Djian J., Drexler H., Feldman A., Kober L., et al. Targeted Anticytokine Therapy in Patients with Chronic Heart Failure. Circulation. 2004;109:1594&#x2013;1602. doi: 10.1161/01.CIR.0000124490.27666.B2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000124490.27666.B2</ArticleId><ArticleId IdType="pubmed">15023878</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung E.S., Packer M., Lo K.H., Fasanmade A.A., Willerson J.T. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (AT) Circulation. 2003;107:3133&#x2013;3140. doi: 10.1161/01.CIR.0000077913.60364.D2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000077913.60364.D2</ArticleId><ArticleId IdType="pubmed">12796126</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulus W.J., Zile M.R. From systemic inflammation to myocardial fibrosis: The hfpef paradigm revisited. Circ. Res. 2021;128:1451. doi: 10.1161/CIRCRESAHA.121.318159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318159</ArticleId><ArticleId IdType="pmc">PMC8351796</ArticleId><ArticleId IdType="pubmed">33983831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning N., Guo H.H., Iagaru A., Mittra E., Fowler M., Witteles R. Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients with Cardiac Sarcoidosis. J. Card. Fail. 2019;25:307&#x2013;311. doi: 10.1016/j.cardfail.2019.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2019.02.018</ArticleId><ArticleId IdType="pubmed">30825644</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelke A.B., Aurangabadkar H.U., Bradfield J.S., Ali Z., Kumar K.S., Narasimhan C. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. Int. J. Cardiol. 2017;228:717&#x2013;722. doi: 10.1016/j.ijcard.2016.11.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.11.142</ArticleId><ArticleId IdType="pubmed">27886616</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasaki F., Azuma A., Anzai T., Ishizaka N., Ishida Y., Isobe M., Inomata T., Ishibashi-Ueda H., Eishi Y., Kitakaze M., et al. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis-Digest Version. Circ. J. 2019;83:2329&#x2013;2388. doi: 10.1253/circj.CJ-19-0508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-19-0508</ArticleId><ArticleId IdType="pubmed">31597819</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnie D.H., Sauer W.H., Bogun F., Cooper J.M., Culver D.A., Duvernoy C.S., Judson M.A., Kron J., Mehta D., Nielsen J.C., et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1304&#x2013;1323. doi: 10.1016/j.hrthm.2014.03.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.03.043</ArticleId><ArticleId IdType="pubmed">24819193</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., Deswal A., Drazner M.H., Dunlay S.M., Evers L.R., et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:E895&#x2013;E1032. doi: 10.1161/CIR.0000000000001063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001063</ArticleId><ArticleId IdType="pubmed">35363499</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., B&#xf6;hm M., Burri H., Butler J., &#x10c;elutkien&#x117; J., Chioncel O., et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2023;44:3627&#x2013;3639. doi: 10.1093/eurheartj/ehad195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad195</ArticleId><ArticleId IdType="pubmed">37622666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng S., Delic D., Chu C., Xiong Y., Luo T., Chen X., Gaballa M.M.S., Xue Y., Chen X., Cao Y., et al. Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet. Biomed. Pharmacother. 2022;146:112606. doi: 10.1016/j.biopha.2021.112606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112606</ArticleId><ArticleId IdType="pubmed">34968924</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Zhang J., Xue M., Li X., Han F., Liu X., Xu L., Lu Y., Cheng Y., Li T., et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc. Diabetol. 2019;18:15. doi: 10.1186/s12933-019-0816-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-019-0816-2</ArticleId><ArticleId IdType="pmc">PMC6359811</ArticleId><ArticleId IdType="pubmed">30710997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M.N., Esterline R., Furtado R.H.M., Oscarsson J., Gasparyan S.B., Koch G.G., Martinez F., Mukhtar O., Verma S., Chopra V., et al. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021;9:586&#x2013;594. doi: 10.1016/S2213-8587(21)00180-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00180-7</ArticleId><ArticleId IdType="pmc">PMC8294807</ArticleId><ArticleId IdType="pubmed">34302745</ArticleId></ArticleIdList></Reference><Reference><Citation>European Society of Cardiology Press Office  SGLT2 Inhibitors not Linked with Improved Survival in Hospitalised COVID-19 Patients.  [(accessed on 3 December 2023)].  Available online:  https://www.escardio.org/The-ESC/Press-Office/Press-releases/SGLT2-inhibitors-not-linked-with-improved-survival-in-hospitalised-COVID-19-patients.</Citation></Reference><Reference><Citation>Abani O., Abbas A., Abbas F., Abbas J., Abbas K., Abbas M., Abbasi S., Abbass H., Abbott A., Abdallah N., et al. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet Diabetes Endocrinol. 2023;11:905&#x2013;914. doi: 10.1016/S2213-8587(23)00253-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(23)00253-X</ArticleId><ArticleId IdType="pubmed">37865101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt B., Agarwal R., Anker S.D., Ruilope L.M., Rossing P., Ahlers C., Brinker M., Joseph A., Lambelet M., Lawatscheck R., et al. Association of Finerenone Use with Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis. JAMA Netw. Open. 2022;5:e2236123. doi: 10.1001/jamanetworkopen.2022.36123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36123</ArticleId><ArticleId IdType="pmc">PMC9606845</ArticleId><ArticleId IdType="pubmed">36287567</ArticleId></ArticleIdList></Reference><Reference><Citation>Henri O., Pouehe C., Houssari M., Galas L., Nicol L., Edwards-L&#xe9;vy F., Henry J.P., Dumesnil A., Boukhalfa I., Banquet S., et al. Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction. Circulation. 2016;133:1484&#x2013;1497. doi: 10.1161/CIRCULATIONAHA.115.020143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.020143</ArticleId><ArticleId IdType="pubmed">26933083</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss H.P., Bock C.T., Aleshcheva G., Baumeier C., Poller W., Escher F. Interferon-&#x3b2; Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial. Viruses. 2022;14:444. doi: 10.3390/v14020444.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020444</ArticleId><ArticleId IdType="pmc">PMC8875228</ArticleId><ArticleId IdType="pubmed">35216037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Lucke C., Spillmann F., Bock T., K&#xfc;hl U., Van Linthout S., Schultheiss H.P., Tsch&#xf6;pe C., Van Linthout S., Schultheiss H.P., Tsch&#xf6;pe C. Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. J. Infect. Dis. 2010;201:936&#x2013;945. doi: 10.1086/650700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/650700</ArticleId><ArticleId IdType="pubmed">20158391</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzai A., Mindur J.E., Halle L., Sano S., Choi J.L., He S., McAlpine C.S., Chan C.T., Kahles F., Valet C., et al. Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis. J. Exp. Med. 2019;216:369. doi: 10.1084/jem.20180722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180722</ArticleId><ArticleId IdType="pmc">PMC6363430</ArticleId><ArticleId IdType="pubmed">30670465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E., Varrenti M., Veronese G., Fanti D., Nava A., Cipriani M., Pedrotti P., Garascia A., Bottiroli M., Oliva F., et al. Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab. Eur. J. Heart Fail. 2021;23:1242&#x2013;1245. doi: 10.1002/ejhf.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2247</ArticleId><ArticleId IdType="pubmed">34036693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Cruz C., Perez-Shibayama C., de Martin A., Ronchi F., van der Borght K., Niederer R., Onder L., L&#xfc;tge M., Novkovic M., Nindl V., et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science. 2019;366:881&#x2013;886. doi: 10.1126/science.aav3487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav3487</ArticleId><ArticleId IdType="pubmed">31727837</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdani S.M., Kim H.S., Orvedahl A., John A.O., Said A., Simpson K. Successful treatment of fulminant neonatal enteroviral myocarditis in monochorionic diamniotic twins with cardiopulmonary support, intravenous immunoglobulin and pocapavir. BMJ Case Rep. 2018;2018:bcr-2017-224133. doi: 10.1136/bcr-2017-224133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2017-224133</ArticleId><ArticleId IdType="pmc">PMC5965763</ArticleId><ArticleId IdType="pubmed">29776940</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug M.J., Michaels M.G., Wald E., Jacobs R.F., Romero J.R., S&#xe1;nchez P.J., Wilson G., Krogstad P., Storch G.A., Lawrence R., et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates with Enterovirus Sepsis. J. Pediatr. Infect. Dis. Soc. 2016;5:53&#x2013;62. doi: 10.1093/jpids/piv015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piv015</ArticleId><ArticleId IdType="pmc">PMC4765488</ArticleId><ArticleId IdType="pubmed">26407253</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen M.H., Huang Y.C., Chen M.C., Liu C.C., Chiu N.C., Lien R., Chang L.Y., Chiu C.H., Tsao K.C., Lin T.Y. Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration. J. Clin. Virol. 2015;64:92&#x2013;96. doi: 10.1016/j.jcv.2015.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.01.013</ArticleId><ArticleId IdType="pubmed">25728086</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U., Lassner D., Wallaschek N., Gross U.M., Krueger G.R.F., Seeberg B., Kaufer B.B., Escher F., Poller W., Schultheiss H.P. Chromosomally integrated human herpesvirus 6 in heart failure: Prevalence and treatment. Eur. J. Heart Fail. 2015;17:9&#x2013;19. doi: 10.1002/ejhf.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.194</ArticleId><ArticleId IdType="pubmed">25388833</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez M.J., Bergasa N. V Hepatitis C associated cardiomyopathy: Potential pathogenic mechanisms and clinical implications. Med. Sci. Monit. 2008;14:RA55&#x2013;RA63.</Citation><ArticleIdList><ArticleId IdType="pubmed">18443562</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik S.H., Jeong H.S., Kim S.J., Yoon Y.K., Sohn J.W., Kim M.J. A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir. Infect. Chemother. 2015;47:272&#x2013;277. doi: 10.3947/ic.2015.47.4.272.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2015.47.4.272</ArticleId><ArticleId IdType="pmc">PMC4716281</ArticleId><ArticleId IdType="pubmed">26788413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito N., Sato M., Momoi N., Aoyagi Y., Endo K., Chishiki M., Kawasaki Y., Hosoya M. Influenza A H1N1 pdm09-associated myocarditis during zanamivir therapy. Pediatr. Int. 2015;57:1172&#x2013;1174. doi: 10.1111/ped.12712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.12712</ArticleId><ArticleId IdType="pubmed">26482326</ArticleId></ArticleIdList></Reference><Reference><Citation>Manaresi E., Gallinella G. Advances in the Development of Antiviral Strategies against Parvovirus B19. Viruses. 2019;11:659. doi: 10.3390/v11070659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070659</ArticleId><ArticleId IdType="pmc">PMC6669595</ArticleId><ArticleId IdType="pubmed">31323869</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;ngen H.D., Dordevic A., Felix S.B., Pieske B., Voors A.A., McMurray J.J.V., Butler J. &#x3b2;1-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications. Circ. Heart Fail. 2020;13:e006155. doi: 10.1161/CIRCHEARTFAILURE.119.006155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.119.006155</ArticleId><ArticleId IdType="pubmed">31957469</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Hilgenfeld R., Whitley R., Clercq E. De Therapeutic strategies for COVID-19: Progress and lessons learned. Nat. Rev. Drug Discov. 2023;22:449. doi: 10.1038/s41573-023-00672-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-023-00672-y</ArticleId><ArticleId IdType="pmc">PMC10113999</ArticleId><ArticleId IdType="pubmed">37076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;323:1824&#x2013;1836. doi: 10.1001/jama.2020.6019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6019</ArticleId><ArticleId IdType="pubmed">32282022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Dai S.M., Tong Q. COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J. Antimicrob. Chemother. 2020;75:1667&#x2013;1670. doi: 10.1093/jac/dkaa114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkaa114</ArticleId><ArticleId IdType="pmc">PMC7184499</ArticleId><ArticleId IdType="pubmed">32196083</ArticleId></ArticleIdList></Reference><Reference><Citation>Rout A., Tantry U.S., Novakovic M., Sukhi A., Gurbel P.A. Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction. Expert Opin. Pharmacother. 2020;21:1851&#x2013;1865. doi: 10.1080/14656566.2020.1787987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2020.1787987</ArticleId><ArticleId IdType="pubmed">32659185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentia C., Rizzato A., Camporesi E., Yang Z., Muntean D.M., S&#x103;ndesc D., Bosco G. An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning. Brain Behav. 2018;8:e00959. doi: 10.1002/brb3.959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.959</ArticleId><ArticleId IdType="pmc">PMC5943756</ArticleId><ArticleId IdType="pubmed">29761012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruegger D., Rehm M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Conzen P., Becker B.F. Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts. Crit. Care. 2008;12:R73. doi: 10.1186/cc6913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6913</ArticleId><ArticleId IdType="pmc">PMC2481466</ArticleId><ArticleId IdType="pubmed">18518977</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch E., Malek F.A. Standardized Extracts from Hawthorn Leaves and Flowers in the Treatment of Cardiovascular Disorders&#x2013;Preclinical and Clinical Studies. Planta Medica. 2011;77:1123&#x2013;1128. doi: 10.1055/s-0030-1270849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1270849</ArticleId><ArticleId IdType="pubmed">21384315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebong E.E., Lopez-Quintero S.V., Rizzo V., Spray D.C., Tarbell J.M. Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1. Integr. Biol. 2014;6:338&#x2013;347. doi: 10.1039/C3IB40199E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C3IB40199E</ArticleId><ArticleId IdType="pmc">PMC3996848</ArticleId><ArticleId IdType="pubmed">24480876</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters W., Drueppel V., Kusche-Vihrog K., Schubert C., Oberleithner H. Nanomechanics and Sodium Permeability of Endothelial Surface Layer Modulated by Hawthorn Extract WS 1442. PLoS ONE. 2012;7:e29972. doi: 10.1371/journal.pone.0029972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029972</ArticleId><ArticleId IdType="pmc">PMC3254622</ArticleId><ArticleId IdType="pubmed">22253842</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreas M., Schmid A.I., Keilani M., Doberer D., Bartko J., Crevenna R., Moser E., Wolzt M. Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: A randomized crossover trial. J. Cardiovasc. Magn. Reson. 2011;13:32. doi: 10.1186/1532-429X-13-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-13-32</ArticleId><ArticleId IdType="pmc">PMC3143996</ArticleId><ArticleId IdType="pubmed">21718491</ArticleId></ArticleIdList></Reference><Reference><Citation>Broekhuizen L.N., Lemkes B.A., Mooij H.L., Meuwese M.C., Verberne H., Holleman F., Schlingemann R.O., Nieuwdorp M., Stroes E.S.G.G., Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 2010;53:2646&#x2013;2655. doi: 10.1007/s00125-010-1910-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-010-1910-x</ArticleId><ArticleId IdType="pmc">PMC2974920</ArticleId><ArticleId IdType="pubmed">20865240</ArticleId></ArticleIdList></Reference><Reference><Citation>Illien-Junger S., Grosjean F., Laudier D.M., Vlassara H., Striker G.E., Iatridis J.C. Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes. PLoS ONE. 2013;8:e64302. doi: 10.1371/journal.pone.0064302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064302</ArticleId><ArticleId IdType="pmc">PMC3656842</ArticleId><ArticleId IdType="pubmed">23691192</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon A.H.J., Ferguson J.K., Burford J.L., Gevorgyan H., Nakano D., Harper S.J., Bates D.O., Peti-Peterd J. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J. Am. Soc. Nephrol. 2012;23:1339&#x2013;1350. doi: 10.1681/ASN.2012010017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2012010017</ArticleId><ArticleId IdType="pmc">PMC3402289</ArticleId><ArticleId IdType="pubmed">22797190</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada N., Maeda M. Chemical structure of antithrombin-active rhamnan sulfate from monostrom nitidum. Biosci. Biotechnol. Biochem. 1998;62:1647&#x2013;1652. doi: 10.1271/bbb.62.1647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1271/bbb.62.1647</ArticleId><ArticleId IdType="pubmed">9805364</ArticleId></ArticleIdList></Reference><Reference><Citation>Giantsos-Adams K., Lopez-Quintero V., Kopeckova P., Kopecek J., Tarbell J.M., Dull R. Study of the therapeutic benefit of cationic copolymer administration to vascular endothelium under mechanical stress. Biomaterials. 2011;32:288&#x2013;294. doi: 10.1016/j.biomaterials.2010.08.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2010.08.092</ArticleId><ArticleId IdType="pmc">PMC4610355</ArticleId><ArticleId IdType="pubmed">20932573</ArticleId></ArticleIdList></Reference><Reference><Citation>Masola V., Zaza G., Onisto M., Lupo A., Gambaro G. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: Biological roles and pharmacological effects. Int. Angiol. 2014;33:243&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">24936533</ArticleId></ArticleIdList></Reference><Reference><Citation>Frati Munari A.C. Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications. Arch. Cardiol. Mex. 2014;84:110&#x2013;116. doi: 10.1016/j.acmx.2013.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acmx.2013.10.006</ArticleId><ArticleId IdType="pubmed">24836779</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja R. Current status of oral pentosan polysulphate in bladder pain syndrome/interstitial cystitis. Int. Urogynecol. J. 2021;32:1107&#x2013;1115. doi: 10.1007/s00192-020-04517-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-020-04517-9</ArticleId><ArticleId IdType="pubmed">32894327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancel L.M., Tarbell J.M. Rhamnan sulfate enhances the endothelial glycocalyx and decreases the LDL permeability of human coronary artery endothelial cells in vitro. FASEB J. 2013;27:896.3. doi: 10.1096/fasebj.27.1_supplement.896.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.27.1_supplement.896.3</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant S.H., Gurule D.M., Larson R.S. Amelioration of ischemia-reperfusion injury with cyclic peptide blockade of ICAM-1. Am. J. Physiol. Heart Circ. Physiol. 2003;284:H1260&#x2013;H1268. doi: 10.1152/ajpheart.00840.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00840.2002</ArticleId><ArticleId IdType="pubmed">12595290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozar R.A., Peng Z., Zhang R., Holcomb J.B., Pati S., Park P., Ko T.C., Paredes A. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth. Analg. 2011;112:1289&#x2013;1295. doi: 10.1213/ANE.0b013e318210385c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e318210385c</ArticleId><ArticleId IdType="pmc">PMC3102787</ArticleId><ArticleId IdType="pubmed">21346161</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez J.I., Martin R.H., Calvillo E., Bershad E.M., Venkatasubba Rao C.P. Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: The ALISAH study. Acta Neurochir. Suppl. 2015;120:287&#x2013;290. doi: 10.1007/978-3-319-04981-6_48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-04981-6_48</ArticleId><ArticleId IdType="pubmed">25366638</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry F.-R.E., Adamson R.H. Sphingosine-1-phosphate and the &#x201c;albumin effect&#x201d; on rat venular microvessels. FASEB J. 2013;27:896.2. doi: 10.1096/fasebj.27.1_supplement.896.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.27.1_supplement.896.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchi&#xe9; A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 2021;21:319&#x2013;329. doi: 10.1038/s41577-021-00536-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., van de Veerdonk F.L., Hoffmeister K.M., et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 2022;22:639&#x2013;649. doi: 10.1038/s41577-022-00762-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevale R., Cammisotto V., Bartimoccia S., Nocella C., Castellani V., Bufano M., Loffredo L., Sciarretta S., Frati G., Coluccia A., et al. Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection. Circ. Res. 2023;132:290&#x2013;305. doi: 10.1161/CIRCRESAHA.122.321541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321541</ArticleId><ArticleId IdType="pubmed">36636919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Lao Q., Zhang J., Zhu J. Coagulopathy in COVID-19 and anticoagulation clinical trials. Best Pract. Res. Clin. Haematol. 2022;35:101377. doi: 10.1016/j.beha.2022.101377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2022.101377</ArticleId><ArticleId IdType="pmc">PMC9395291</ArticleId><ArticleId IdType="pubmed">36494146</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A., Chakraborty U., Ghosh S., Dasgupta S. Anticoagulation in COVID-19: Current concepts and controversies. Postgrad. Med. J. 2022;98:395&#x2013;402. doi: 10.1136/postgradmedj-2021-139923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-139923</ArticleId><ArticleId IdType="pubmed">33850011</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav P., Kumar D., Meena D.S., Naresh K.M., Bohra G.K., Garg M.K., Purohit A.H.L. Post-Discharge Prophylactic Anticoagulation in COVID-19 Patients: A Clinical Dilemma. Cardiovasc. Hematol. Disord. Drug Targets. 2021;21:206&#x2013;209. doi: 10.2174/1871529X21666210914113752.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871529X21666210914113752</ArticleId><ArticleId IdType="pubmed">34521335</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone G.W., Farkouh M.E., Lala A., Tinuoye E., Dressler O., Moreno P.R., Palacios I.F., Goodman S.G., Esper R.B., Abizaid A., et al. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized with COVID-19. J. Am. Coll. Cardiol. 2023;81:1747. doi: 10.1016/j.jacc.2023.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.02.041</ArticleId><ArticleId IdType="pmc">PMC9987252</ArticleId><ArticleId IdType="pubmed">36889611</ArticleId></ArticleIdList></Reference><Reference><Citation>He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 2006;13:393&#x2013;403. doi: 10.1038/sj.cdd.4401833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401833</ArticleId><ArticleId IdType="pubmed">16397582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur S. Double-Stranded RNA Sensors and Modulators in Innate Immunity. Annu. Rev. Immunol. 2019;37:349&#x2013;375. doi: 10.1146/annurev-immunol-042718-041356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041356</ArticleId><ArticleId IdType="pmc">PMC7136661</ArticleId><ArticleId IdType="pubmed">30673536</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddell J.R. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration? Antioxidants. 2017;6:65. doi: 10.3390/antiox6030065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox6030065</ArticleId><ArticleId IdType="pmc">PMC5618093</ArticleId><ArticleId IdType="pubmed">28820437</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivarini &#xc1;islan de C., Calegari-Silva T.C., Saliba A.M., Boaventura V.S., Fran&#xe7;a-Costa J., Khouri R., Dierckx T., Dias-Teixeira K.L., Fasel N., Barral A.M.P., et al. Systems approach reveals nuclear factor erythroid 2-related factor 2/protein kinase r crosstalk in human cutaneous leishmaniasis. Front. Immunol. 2017;8:283936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605755</ArticleId><ArticleId IdType="pubmed">28959260</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreas M., Schmid A.I., Doberer D., Schewzow K., Weisshaar S., Heinze G., Bilban M., Moser E., Wolzt M. Heme arginate improves reperfusion patterns after ischemia: A randomized, placebo-controlled trial in healthy male subjects. J. Cardiovasc. Magn. Reson. 2012;14:55. doi: 10.1186/1532-429X-14-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-14-55</ArticleId><ArticleId IdType="pmc">PMC3438022</ArticleId><ArticleId IdType="pubmed">22857721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hangaishi M., Ishizaka N., Aizawa T., Kurihara Y., Taguchi J.I., Nagai R., Kimura S., Ohno M. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem. Biophys. Res. Commun. 2000;279:582&#x2013;588. doi: 10.1006/bbrc.2000.3973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.3973</ArticleId><ArticleId IdType="pubmed">11118329</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Zhang B., Wei X., Cui X., Kobayashi T. Effects of heme oxygenase 1 on brain edema and neurologic outcome after cardiopulmonary resuscitation in rats. Anesthesiology. 2008;109:260&#x2013;268. doi: 10.1097/ALN.0B013E31817F5C2E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0B013E31817F5C2E</ArticleId><ArticleId IdType="pubmed">18648235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ligi D., Lo Sasso B., Giglio R.V., Maniscalco R., DellaFranca C., Agnello L., Ciaccio M., Mannello F. Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis. Crit. Care. 2022;26:260. doi: 10.1186/s13054-022-04138-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04138-2</ArticleId><ArticleId IdType="pmc">PMC9424804</ArticleId><ArticleId IdType="pubmed">36042461</ArticleId></ArticleIdList></Reference><Reference><Citation>Semeraro F., Ammollo C.T., Morrissey J.H., Dale G.L., Friese P., Esmon N.L., Esmon C.T. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: Involvement of platelet TLR2 and TLR4. Blood. 2011;118:1952&#x2013;1961. doi: 10.1182/blood-2011-03-343061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-03-343061</ArticleId><ArticleId IdType="pmc">PMC3158722</ArticleId><ArticleId IdType="pubmed">21673343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Eichelberger B., Kopp C.W., Pultar J., Seidinger D., Koppensteiner R., Lang I.M., Panzer S., Gremmel T. Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy. J. Cardiovasc. Transl. Res. 2017;10:359&#x2013;367. doi: 10.1007/s12265-017-9746-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-017-9746-0</ArticleId><ArticleId IdType="pmc">PMC5585279</ArticleId><ArticleId IdType="pubmed">28425039</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzer B., Wadowski P.P., Huber K., Panzer S., Gremmel T. Protease-activated receptor-mediated platelet aggregation in patients with type 2 diabetes on potent P2Y12 inhibitors. Diabet. Med. 2022;39:e14868. doi: 10.1111/dme.14868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.14868</ArticleId><ArticleId IdType="pmc">PMC9546030</ArticleId><ArticleId IdType="pubmed">35514270</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Pultar J., Weikert C., Eichelberger B., Panzer B., Huber K., Lang I.M., Koppensteiner R., Panzer S., Gremmel T. Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors. Res. Pract. Thromb. Haemost. 2019;3:383&#x2013;390. doi: 10.1002/rth2.12213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12213</ArticleId><ArticleId IdType="pmc">PMC6611376</ArticleId><ArticleId IdType="pubmed">31294325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofosu F.A., Dewar L., Craven S.J., Song Y., Cedrone A., Freedman J., Fenton J.W. Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin. J. Biol. Chem. 2008;283:26886&#x2013;26893. doi: 10.1074/jbc.M802237200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802237200</ArticleId><ArticleId IdType="pubmed">18682394</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremmel T., Michelson A.D., Wadowski P.P., Pultar J., Weikert C., Tscharre M., Lee S., Panzer S., Frelinger A.L. Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization. Atherosclerosis. 2021;339:12&#x2013;19. doi: 10.1016/j.atherosclerosis.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2021.11.011</ArticleId><ArticleId IdType="pubmed">34808540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Weikert C., Pultar J., Lee S., Eichelberger B., Koppensteiner R., Lang I.M., Panzer S., Gremmel T. Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes. Cardiovasc. Drugs Ther. 2020;34:53&#x2013;63. doi: 10.1007/s10557-019-06932-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-019-06932-7</ArticleId><ArticleId IdType="pmc">PMC7093367</ArticleId><ArticleId IdType="pubmed">32062795</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Heijden M., Van Nieuw Amerongen G.P., Koolwijk P., Van Hinsbergh V.W.M., Groeneveld A.B.J. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax. 2008;63:903&#x2013;909. doi: 10.1136/thx.2007.087387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2007.087387</ArticleId><ArticleId IdType="pubmed">18559364</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau A., Schroeter N., Blazhenets G., Dressing A., Walter L.I., Kellner E., Bormann T., Mast H., Wagner D., Urbach H., et al. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain. 2022;145:3203&#x2013;3213. doi: 10.1093/brain/awac045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac045</ArticleId><ArticleId IdType="pmc">PMC9214163</ArticleId><ArticleId IdType="pubmed">35675908</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci M., Oudenaarden C., S&#xe0;enz-sard&#xe0; X., Simr&#xe9;n J., Ed&#xe9;n A., Sj&#xf6;lund J., M&#xf6;ller C., Gissl&#xe9;n M., Zetterberg H., Englund E., et al. Infection of brain pericytes underlying neuropathology of covid-19 patients. Int. J. Mol. Sci. 2021;22:11622. doi: 10.3390/ijms222111622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111622</ArticleId><ArticleId IdType="pmc">PMC8583965</ArticleId><ArticleId IdType="pubmed">34769052</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotides N.G., Zimprich F., Machold K., Schlager O., M&#xfc;ller M., Ertl S., L&#xf6;ffler-Stastka H., Koppensteiner R., Wadowski P.P. A Case of Autoimmune Small Fiber Neuropathy as Possible Post COVID Sequelae. Int. J. Environ. Res. Public Health. 2023;20:4918. doi: 10.3390/ijerph20064918.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20064918</ArticleId><ArticleId IdType="pmc">PMC10049708</ArticleId><ArticleId IdType="pubmed">36981826</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones O.Y., Yeralan S. Is Long COVID a State of Systemic Pericyte Disarray? J. Clin. Med. 2022;11:572. doi: 10.3390/jcm11030572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030572</ArticleId><ArticleId IdType="pmc">PMC8836446</ArticleId><ArticleId IdType="pubmed">35160024</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdi A., AlOtaiby S., Al Badarin F., Khraibi A., Hamdan H., Nader M. Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy. Biomed. Pharmacother. 2022;146:112518. doi: 10.1016/j.biopha.2021.112518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112518</ArticleId><ArticleId IdType="pmc">PMC8654598</ArticleId><ArticleId IdType="pubmed">34906770</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey T.M., Ziegler C.G.K., Heimberg G., Normand R., Yang Y., Segerstolpe &#xc5;., Abbondanza D., Fleming S.J., Subramanian A., Montoro D.T., et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellulartargets. Nature. 2021;595:107. doi: 10.1038/s41586-021-03570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Katwa L.C., Mendoza C., Clements M. CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts. Cells. 2022;11:1316. doi: 10.3390/cells11081316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11081316</ArticleId><ArticleId IdType="pmc">PMC9031661</ArticleId><ArticleId IdType="pubmed">35455995</ArticleId></ArticleIdList></Reference><Reference><Citation>Daems M., Liesenborghs L., Boudewijns R., Simmonds S.J., Kraisin S., Van Wauwe J., Cuijpers I., Raman J., Geuens N., Van Buyten T., et al. SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1&#x3b1; translocation in an animal model COVID-19. Front. Cardiovasc. Med. 2022;9:964512. doi: 10.3389/fcvm.2022.964512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.964512</ArticleId><ArticleId IdType="pmc">PMC9618878</ArticleId><ArticleId IdType="pubmed">36324747</ArticleId></ArticleIdList></Reference><Reference><Citation>Avolio E., Carrabba M., Milligan R., Williamson M.K., Beltrami A.P., Gupta K., Elvers K.T., Gamez M., Foster R.R., Gillespie K., et al. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: A potential non-infective mechanism of COVID-19 microvascular disease. Clin. Sci. 2021;135:2667&#x2013;2689. doi: 10.1042/CS20210735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20210735</ArticleId><ArticleId IdType="pmc">PMC8674568</ArticleId><ArticleId IdType="pubmed">34807265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>